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Abstract 
Background: Anxiety levels are known to be elevated following a Myocardial 
Infarction (MI). If untreated, results can lead to depression and an increase in recurrent 
events (Frasure-Smith, Lesperance, Talajic, 1994). Patients undergoing thrombolysis 
to treat their MI remain in hospital for approximately 5 days. The introduction of 
Primary Percutaneous Coronary Intervention (PPCI) has seen the Bristol Royal 
Infirmary (BRI) reduce PPCI patients’ length of stay to an average of 2.7 days (Oriolo 
& Tagney, 2011). There is little evidence to indentify if this results in positive or 
negative effects on patient anxiety and depression. Length of in-patient stay affects 
patient’s ability to absorb information (Astin et al 2008a). A short stay in hospital may 
affect anxiety due to less time spent on providing information and support to patients 
and their families. It is possible prolonged recovery or increased readmissions could 
be due to anxiety issues. The study aim is to investigate if anxiety and depression 
levels in PPCI patients from South Bristol result in different outcomes compared to 
Thrombolysis patients. 
 Study design: A retrospective study of patients admitted to BRI with a first time 
STEMI treated with either Thrombolysis or PPCI from April 2004 to March 2010. The 
study will provide insight into patients’ motivation to lifestyle changes. Overall, the 
study will identify improvement or deterioration in patient recovery from an MI with 
the introduction of PPCI. 
Method: Myocardial Ischemia National Audit Project (MINAP) provided patient 
identification data. MINAP data was matched with the BRI Cardiac Rehabilitation 
Patient Audit tracking System (CRPATS). Hospital anxiety and depression scores 
(HADS) were used, to measure emotional outcomes. Readmission data was collected 
from PATS, hospital and patient medical records. Cardiac rehabilitation attendance 
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and lifestyle outcomes were obtained from CRPATS data. Patient information remains 
anonymous for the purpose of this study. Application of the Statistical Package for the 
Social Sciences (SPSS) calculated statistical analysis. 
Findings: Unplanned re-admissions occurred sooner for PPCI patients at the BRI (p = 
.034) as did cardiac related re-admissions (p = .049). A significant link exists with 
PPCI increased number of cardiac related re-admissions and increased phase II 
depression scores (P = .024). PPCI patients had shorter hospital admissions following 
their initial event (P = .005).  PPCI deaths occurred earlier than Thrmobolysis (P = 
.001) Shorter hospital admissions were linked to increased  phase II depression (P = 
.041), phase III anxiety scores (P = .031) anxiety levels (P = .009)  in thrombolysis 
patients. PPCI patients anxiety improved at phase III compared with Thrombolysis (p 
= .031). Thrombolysis depression levels and scores demonstrate significant reductions 
between phases (P = .037). Female anxiety scores were higher than male at phase III 
(P = .019). Cholesterol and Smoking improved between phase II and III. Activity 
decreased in both treatments between phases. Longer admissions were linked to 
decreased diastolic blood pressure, weight and alcohol. Females have poorer outcomes 
in terms of risk factor management between phase II and III cardiac rehabilitation than 
males. 
Conclusion: The introduction of PPCI has not been detrimental to South Bristol 
patients outcomes. More prospective studies are necessary to identify if links with 
length of stay, readmission time and premature deaths are valid amongst PPCI 
patients. Further investigation is necessary to find reasons behind reduced activity and 
poorer outcomes for females at phase III.   (544 words) 
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1. Introduction 
1.1 General Overview  
Cardiovascular Disease is one of the main causes of premature death in the United 
Kingdom (UK) accounting for almost 191,000 deaths each year or one in every three 
deaths, of which 46% are due to Coronary Heart Disease (CHD) (British Heart 
Foundation BHF, 2010). Treatments for prevention of cardiac deaths have developed 
rapidly over the last forty years. Revascularisation treatments have become 
commonplace for conditions such as angina and Myocardial Infarction (MI) with 
Coronary Artery Bypass Graft (CABG) surgery becoming routine in the mid 1970’s 
(British Heart Foundation Health promotion Research Group, 2010). Nearly 23,000 
CABG operations were performed in the UK by the year 2008.  Andreas Gruntzig 
pioneered percutaneous coronary intervention (PCI) treatments for coronary vessel 
disease in 1979 with successful reduction of stenosis in 32 out of 50 patients 
(Grüntzig, Senning, & Siegenthaler, 1979a). Today PCI is a routine treatment for 
patients with CHD. By 2008 PCI interventions exceeded 80,000 in the UK (British 
Heart Foundation Health promotion Research Group, 2010).  
Further development of PCI treatment involved replacing thrombolysis and rescue PCI 
for ST elevation myocardial infarction (STEMI) patients with Primary PCI (PPCI).  
Stone, McDonnell, Richardson, Grines, O’Neill, & Jones (1998) concluded PPCI 
stents to be a safe alternative to thrombolysis in a majority of STEMI patients as their 
findings demonstrated excellent outcomes in the short term. The procedure has proved 
to be the most beneficial in terms of patient outcomes and hospital stay.  
PPCI is recommended, by the European Society of Cardiology (ESC) (2008), as the 
first line of treatment for STEMI patients. 
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It is well known anxiety levels are high in the immediate time following an MI. 
Evidence has highlighted post MI depression can increase patient risk for further 
cardiac events (Frasure-Smith, Lespérance, Talajic, 1994). The introduction of routine 
PPCI over the last 5 years has seen patients discharged within three days of their 
initiating event (Laarman & Dirkson, 2010). There is little evidence to indentify if this 
results in a positive or negative effect on patient anxiety levels. Reports claim length 
of in-patient stay affects patient’s ability to absorb information (Astin, Closs, 
McLenachan, Hunter, & Priestley, 2008b). It is possible a short stay in hospital could 
lead to increased anxiety due to less health professionals time spent on providing 
information and support to patients and their families. The National Infarct 
Angioplasty Project (2007) highlight concern regarding insufficient time allowed for 
patients and healthcare professionals to reflect, together, on events and discuss their 
next steps because the PPCI process was so fast. It is possible prolonged recovery or 
increased readmissions could be due to anxiety issues.  Alternatively, anxiety levels 
may seem lower in PPCI patients as they underestimate the seriousness of their cardiac 
event, therefore failing to realise the importance of addressing lifestyle changes to 
prevent secondary events and compliance to medical treatment. 
Recent changes to the Government NHS strategy (Secretary of State for Health, 2010),   
has emphasized the need for clinical practice to be more patient-centred. 
Understanding patients’ experiences of treatment and exploring their needs will enable 
health services in their drive toward better patient care.  
1.2 Cardiac Services in Bristol 
CHD is one of the main causes of death in Bristol with a mortality rate of 109 per 
100,000 people. From 2004 to 2006, forty eight percent of deaths in Bristol were due 
to CHD and twenty seven percent of all circulatory disease was aged under 75years. 
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This figure is predicted to rise as issues of obesity increase and the population ages 
(English Public Health Observatories, 2011). 
Pre-hospital thrombolysis was implemented in Bristol in 2002 with rescue PCI 
accessed at Bristol Royal Infirmary (BRI) in 2004. Cardiologists piloted PPCI at the 
BRI in 2003. The success of PPCI interventions led to the development of the 
‘Optimum Reperfusion Programme’ involving structured pathways for patients 
identified with STEMI (Kendall, 2007).  By 2007, the BRI was set up to provide a 
twenty four hour PPCI service for their catchment area. The service extended to North 
Somerset, Bristol (North and South) and South Gloucester in 2009. BRI cardiac 
services currently provide a twenty-four hour a day service for the Gloucester, 
Wiltshire, Avon and Somerset network (GWAS) region. The introduction of PPCI and 
nurse led discharge has subsequently reduced BRI patients’ length of stay to an 
average of 2.7 days following a STEMI (Oriolo & Tagney, 2011). Patients are seen by 
a Cardiac Rehabilitation Specialist Nurse prior to discharge. All MI patients are 
referred for Cardiac Rehabilitation at in-patient stage. Referrals are sent to patients 
local Cardiac Rehabilitation team if they are from out of area. 
This study is a retrospective review of cardiology treatment for patients admitted to 
the BRI with an STEMI. Comparing PPCI and Thrombolysis patient outcomes will 
identify if a shorter hospital stay has an impact on patient’s anxiety and depression 
levels, readmissions, mortality and if they remain compliant with lifestyle advice. 
1.3 Aims and Objectives  
The aim of this study is to compare patients treated with PPCI or thrombolysis to 
determine if outcomes remain consistent between treatments at the BRI.  To achieve 
this aim, data was analysed to satisfy the following objectives: 
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i- Identify if PPCI results in more or less unplanned readmissions in STEMI 
patients compared to thrombolysis patients. 
ii- Identify any significance in frequency and reasons for non-planned 
readmission to hospital between the two groups.  
iii- Explore mortality rates between both groups. 
iv- Identify if uptake of cardiac rehabilitation amongst PPCI differs to 
thrombolysis patients. 
v - Identify if a shorter hospital stay following PPCI results in increased or 
decreased anxiety or depression compared to thrombolysis patients who remain 
in hospital for longer periods.  
vi - Identify differences in anxiety and depression levels between PPCI and 
thrombolysis patients at phase two and three of cardiac rehabilitation in the 
Bristol area. 
vii - Any significant difference in risk factor management between PPCI and 
thrombolysis patients 
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2. Literature Review 
The literature available in respect of this study is limited in terms of comparing 
anxiety and depression for different STEMI treatments. However, the psychological 
aspect has been a growing concern in terms of patients who survive an MI. With PPCI 
being a relatively new procedure in terms of MI treatment, long-term outcomes have 
yet to be deduced. Many studies have identified issues with recovery of patients 
following diagnosis and treatment for CHD events. The following literature review 
demonstrates a vast overlap in terms of MI treatments and the influence of education, 
length of stay, patients’ perceptions and social circumstances on the development of 
post MI complications, mortality, lifestyle, anxiety and depression. Results of such 
studies have enabled health care professionals to develop and modify treatments and 
interventions in order to provide the best possible outcomes for cardiac patients and 
their families and carer’s.  
2.1 What is a Myocardial Infarction? 
The heart is an organ made of muscle called the myocardium. It contains chambers 
and valves that help move blood through the heart and lungs. Its function is to pump 
blood around the body, via arteries and veins, in order to supply blood and oxygen to 
organs and muscles. The heart needs its own blood supply to function. The vessels 
supplying blood to the heart are known as Coronary Arteries and Coronary Veins 
(Brubaker, Kaminsky, & Whaley, 2002). Heart disease develops over many years. 
Ross (1999) conducted extensive studies into the development of coronary artery 
disease. His studies revealed the development of atherosclerotic disease was caused by 
the accumulation of lipids in the artery walls. Ross went on to examine the effect of 
atherosclerosis and concluded it to be an inflammatory response that can lead to the 
formation of lesions within the arteries. High levels of plasma cholesterol, particularly 
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low density lipoprotein (LDL) cholesterol, builds up in damaged areas of the smooth 
muscle within the arteries. Damage can occur through smoking, high blood pressure, 
diabetes, genetic changes and high levels of LDL. As cholesterol adheres within the 
artery walls, a lesion is formed, also known as a fatty streak. The reaction of cells, 
such as macrophages and lymphocytes, respond to the damage and attempt to repair 
the arterial wall. The result is remodelling of the artery through thickening and fibrosis 
of the smooth muscle tissue. Eventually a fibrosis cap, known as plaque, will form to 
cover the lipid core. The pressure of the expanding lesion results in a protrusion into 
the arterial lumen, which restricts the flow of blood, known as ischaemia. Some people 
may experience symptoms of angina at this stage. Angina occurs when the heart is 
under exertion. The heart muscles demand for blood and oxygen increases but the 
restricted coronary artery cannot meet the demand. If undetected or untreated, the 
plaque will eventually rupture. The body responds to the rupture as it does with any 
damaged tissue and forms a thrombus or blood clot around the damaged area. This 
results in an occlusion of the artery, thus stopping the flow of blood to the heart 
muscle. The longer the myocardium is without a blood supply, the greater the risk of 
irreparable damage to the muscle cells, known as infarction. Myocardial cells begin to 
break down within 60 minutes of cessation of blood supply. A complete blockage of a 
coronary artery can be identified through changes to electrocardiograph (ECG) 
recordings known as ST elevation, thus the term ST elevation myocardial infarction 
(STEMI).  
2.2 Treatments for an ST Elevation Myocardial Infarction 
The National Institute for Clinical Excellence (NICE) (2002) produced guidelines 
recommending the use of thrombolytic drugs for the treatment of acute MI’s. A review 
of studies into the use of the drug concluded it to be a safe and cost effective method 
of treatment. Thrombolytic drugs are administered intravenously and help to break 
Fiona Barnard                    MSc Cardiac Rehabilitation Dissertation.                September 2011 
 
7 
 
down the coronary thrombus to restore blood flow to the heart muscle. If restoration of 
blood flow is fast enough, the myocardium will sustain less permanent damage.  
Thrombolytic drugs is safely administered up 12 hours after the onset of STEMI 
symptoms. However, the treatment carries certain risks such as hypotension and 
bleeding due to the anti thrombolytic effect (National Institute for Clinical Excellence 
Appraisal Committee, 2002).  
Gruentzig successfully introduced the use of balloon catheters for the treatment of  
occluded arteries in 1977 (Gruntzig & Kumpe, 1979b). Puel and Sigwart first 
implanted human stents in 1977 (Serruys, Kutryk, & Ong, 2006). The technique has 
developed over the years and today PPCI is recommended as the first line intervention 
for patients presenting with a STEMI (McLenachan, Machin, & Marley, 2009).   
The procedure is performed with the patient fully awake. A fine bore catheter is 
introduced, percutaneously, through an artery, either femoral or radial. The catheter is 
guided to the aorta and positioned close to the coronary sinus. A radio opaque contrast 
is injected through the catheter and into the coronary arteries. Recorded angiographic 
images are examined by the cardiologist in order to locate the occlusion. A guide wire 
is then introduced into the catheter and placed at the point of the lesion. The tip of the 
guide wire consists of a small balloon with a mesh tube or stent compressed over the 
outside. When the guide wire tip is in place, the balloon is inflated causing the stent to 
expand and open the occluded artery. The balloon is deflated and removed, along with 
the catheter, leaving the stent in place (Brubaker, Kaminsky, & Whaley, 2002). 
Results are usually instantaneous and the patient begins to feel instant relief. A Danish 
study into effective treatment for STEMI patients identified the time between onset of 
symptoms and treatment influenced patient outcomes in terms of permanat myocardial 
damage and survival. Recommendations are that PPCI should be performed within 
120 minutes of the patients initial call for help (DANAMI-2 Investigators, 2003) . 
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2.3 Anxiety and Depression post MI 
Many studies explore the links with depression and CHD.  Evidence has found strong 
associations of depression and death following an MI (table 1).  
Table 1: Literature relating to post MI anxiety and depression 
Author & 
Year 
Study Title Group 
Type 
Study Type Assessment Tool Size (n) Findings 
Bush et al, 
2001 
Minimal 
Symptoms of  
Depression 
Increase 
Mortality Risk 
After AMI 
MI Prospective 
study 
Structured Clinical 
Interview for DSM 
III R.  
Beck Depression 
Inventory 
285 Highest mortality rates were in  
patients with most severe  
depressive symptoms. Compared  
with those without depression,  
higher mortality was also observed at  
very low levels of depressive symptoms  
Chung  
et al, 2007 
Co morbidity 
and personality 
traits in 
patients with 
different levels 
of 
posttraumatic 
stress disorder 
following MI 
MI Prospective 
control study 
Posttraumatic 
Stress Diagnostic 
Scale. 
General Health 
Questionnaire-28. 
NEO-Five Factor 
Inventory 
120 Following MI, those with full  
PTSD reported more severe co  
morbidity than those who have  
not developed PTSD fully. 
Chung  
et al, 2008 
Coping with 
posttraumatic 
stress disorder 
and co 
morbidity after 
MI 
MI Prospective 
research  
(post MI 
mean 5 to 7 
years) 
Posttraumatic 
Stress 
Diagnostic Scale, 
General Health 
Questionnaire,  
COPE Scale 
120 31% patients had PTSD 
Intervention increased PTSD. Avoidance 
increased co-morbidity symptoms i.e. 
depression 
Denollet 
et al, 1995 
Personality 
and Mortality 
After MI 
MI Prospective 
study 
Social Inhibition 
scale of the Heart 
Patients 
Psychological 
Questionnaire. 
State Trait Anxiety 
Inventory. 
Millon Behavioural 
Health Inventory. 
105 men The distressed personality type was 
associated with post MI mortality. 
Denollet 
et al, 2006 
Recognizing 
Increased Risk 
of Depressive 
Co morbidity 
after MI: 
Looking for 4 
Symptoms of 
Anxiety-
Depression 
MI Prospective 
trial 
Psychiatric 
Interview.  
Beck Depression 
Inventory. 
Symptoms 
of Anxiety-
Depression index 
176 Symptoms of anxiety and depression co-
occurred after MI. Mixed anxiety-
depression was independently associated 
with depressive or anxiety disorder. 
Doering  
et al, 2009 
Persistent co 
morbid 
symptoms of 
depression and 
anxiety predict 
mortality in 
heart disease 
IHD Prospective 
randomized 
trial (3 to 12 
months 
following 
MI) 
Multiple Adjective 
Affect Checklist, 
Brief Symptom 
Inventory 
2,325 61.7% patients reported depression, 
anxiety or both. 
3.8% of patient deaths within 12 months 
had both 
ENRICH
D 2005 
Low Perceived 
Social Support 
and Post–MI 
Prognosis in 
MI Qualitative 
and 
Quantative 
Clinical 
ENRICHD Social 
Support 
Instrument. 
Depression 
1,503 LPSS risk reported improvement in 
perceived support, regardless of 
treatment. Significant treatment effect in 
LPSS group with no partner and 
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the Enhancing 
Recovery in 
CHD Clinical 
Trial 
Trial (29 
months) 
Interview and 
Structured 
Hamilton. 
Beck 
Depression 
Inventory 
moderate support at baseline. During 29-
month follow-up, combined end point of 
death / nonfatal MI = 10% in MI 
comparison group and 23% in ENRICHD 
LPSS patients; LPSS conferred a greater 
risk in unadjusted and adjusted models.  
Frasure-
Smith  
et al, 1995 
Depression 
and 18Month 
Prognosis 
After MI 
MI Prospective 
study 
National Institute 
of Mental Health 
Diagnostic 
Interview 
Schedule. 
Beck Depression 
Inventory. 
222  DIS and elevated BDI scores were 
significantly related to 18month cardiac 
mortality. Deaths were concentrated 
among depressed patients with premature 
ventricular contractions of more than 10 
per hour. 
Kawachi, 
et al., 
1994 
Prospective 
study of 
phobic anxiety 
and risk of 
CHD in men 
CHD  Cohort 
(prospective 
2 years) 
Crown-Crisp 
experiential index 
33,999 men No risk of phobic risk with non-fatal MI. 
High risk of fatal MI if phobic score > 3. 
Relative risk increases for men with a 
history of CHD. 
Linke et 
al,  2009 
Depressive 
Symptom 
Dimensions 
and 
Cardiovascular 
Prognosis 
Among 
Women With 
Suspected MI 
MI Cohort study 
(continuous 
follow-up 
median of 
5.8 years 
post MI) 
Beck Depression 
Inventory, 
Coronary 
Angiography 
550 women Somatic but not cognitive affective / 
depressive symptoms were associated 
with an increased risk of cardiovascular-
related mortality and events. 
May et al, 
2009 
Depression 
After CAD Is 
Associated 
With Heart 
Failure 
CAD Prospective 
research 
(From CAD 
diagnosis to 
death or HF) 
Anti-depressant 
medication 
(ADM), 
Clinical diagnosis 
13,708 10% post CAD had clinical depression. 
16.4% with post CAD depression 
developed heart disease (p < 0.0001) 
Naqvi et 
al, 2005 
Gender 
Differences in 
the Link 
Between 
Depression 
and 
Cardiovascular 
Disease 
MI 
and 
CHD 
Literature 
review 
None specific Not 
specified 
Depression delays recovery in women 
post MI and CABG. 
Pedersen 
et al, 2002 
The role of 
personality 
variables and 
social support 
in distress and 
perceived 
health in 
patients 
following MI 
MI Prospective 
study 4-6 
weeks post 
MI 
The Posttraumatic 
Diagnostic Scale. 
Trauma Symptom 
Checklist. 
Health Complaints 
Scale. 
Eysenck 
Personality 
Questionnaire. 
Personality Type D 
Scale. 
Crisis Support 
Scale. 
112 Low social support = t increased risk of 
depression and PTSD. Less satisfaction 
with support = increased risk of anxiety, 
depression, PTSD, and more reported 
health complaints. Neuroticism was an 
independent predictor of all types of 
distress and health complaints. 
Satisfaction with support only remained 
an independent predictor of depression. 
Rees et al, 
2004 
Psychological 
interventions 
for CHD 
CHD Systematic 
Review 
Literature Review Thirty six 
trials with 
12,841 
patients 
Unclear results, but inclusion in 
rehabilitation programmes may help. 
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Roest et 
al, 2010 
Prognostic 
Association of 
Anxiety Post 
MI  With 
Mortality 
and New 
Cardiac Events 
MI Meta-
Analysis 
Non specified 12 Studies 
total 5750 
patients 
average 2.6 
years follow 
up 
 
Anxious patients were at risk of adverse 
events. Anxiety was specifically 
associated with all-cause mortality, 
cardiac mortality and new cardiac events. 
Post-MI anxiety is associated with a 36% 
increased risk of adverse cardiac 
outcomes. 
Roest et 
al, 2010 
Anxiety and 
Risk of 
Incident CHD 
CHD Meta-
analysis 
None specified 20 studies 
totalling 
 249,846 
subjects 
Anxious persons were at risk of CHD and 
cardiac death. There was a non-
significant trend for an association 
between anxiety and nonfatal MI. 
Shen et al, 
2008 
Anxiety 
Characteristics 
Independently 
and 
Prospectively 
Predict MI in 
Men 
MI  Predictive 
Longitudinal 
Study (12.4 
years) 
Minnesota 
Multiphasic 
Personality 
Inventory (MMPI) 
735 men Anxiety-prone dispositions appear to be a 
robust and independent risk factor of MI 
among older men. 
Stafford 
et al, 2009 
Are illness 
perceptions 
about CAD 
predictive of 
depression and 
quality of life 
outcomes? 
CAD Prospective 
research (3 
and 9 
months post 
vent) 
Hospital anxiety 
and Depression 
(HADS), 
Health-Related 
Quality of Life 
(HRQOL). 
193 Negative beliefs predict increased 
depression symptoms. Older and socially 
disadvantaged patients had greater 
negative beliefs. 
Thombs 
et al, 2008 
Usefulness of 
Persistent 
Symptoms of 
Depression to 
Predict 
Physical 
Health Status 
12 Months 
After an ACS 
ACS Prospective 
research (12 
months) 
Beck Depression 
Inventory (BDI) 
Short Form 12 (SF-
12) 
425 Patients with persistent symptoms of 
depression were at risk of poorer physical 
health. Patients with newly developed 
depressive symptoms after ACS were at 
slightly increased risk for worsened 
physical health (p= 0.060), whereas 
patients with transient depressive 
symptoms were not at increased risk. 
 
Frasure-Smith, Lespérance, Talajic, (1994) identified elevated depression scores were 
related to 18 month cardiac mortality. They investigated a notable link of depression 
with cardiac arrhythmias and found a concentration of elevated depression scores and 
premature ventricular beats of more than 10 per hour among those patients that had 
died. Consequently, depression has remained of great interest to researchers with a 
view to further define its links with heart disease. However, less emphasis was placed 
on the effect anxiety has in relation to heart disease in the long and short term. 
However, recent introduction of new techniques to treat CVD and faster throughput in 
hospitals has influenced researchers to examine the effects of anxiety as well as 
depression on patients with CHD.  
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The Health Professionals Follow Up study took place in America from 1986. It 
involved a population of over 51,000 men. Analysis of the data involved identification 
of psychological and personality traits to find associations with CHD. The study group 
aimed to find links with self reported phobic anxiety and CHD (Kawachi, Colditz, 
Ascherio, Rimm, Giovannucci, Stampfer & Willett, 1994).  Their findings were 
significant relative risks of fatal MI associated with a phobic anxiety score of three or 
more. Risks increased when the study’s variable adjustments included men with a 
history of CHD. They found no links with non-fatal MI and phobic anxiety scores. 
In support of Kawachi et al (1994) results, extensive studies into personality traits and 
their effects on patient mortality following an MI have further revealed significant 
links with depression and anxiety over the years. Denollet, Sys, Brutsaert, (1995) 
identified distressed personality types to have higher risks of post MI mortality. 
Denollets continued investigations into psychological issues related to CHD, 
highlighted the issue of depression and anxiety being consistently overlooked in 
patients suffering an MI (Denollet, Strik, Lousberg, & Honig, 2006). They found 
levels of anxiety were high in patients with depression and was present in all with 
severe depression. The implications of co morbidity result in an increase risk of 
mortality and increase burden on health services emphasising the need to address 
anxiety as a core feature of depression assessing patients following an MI. 
Further research has exposed anxiety as a predictor for MI. Shen, Avivi, Todaro, 
Spiro, Laurenceau, Ward & Niaura, (2008) identified anxiety as a significant risk 
factor in older men with no history of heart disease. Their study examined data from 
the Normative Ageing Study (NAS Boston). Analysis of various psychological and 
physical assessments of older men with a mean age of 60 years revealed them to be at 
risk of an MI within 12 years if they demonstrated moderate to high levels of anxiety. 
Their study concludes that severe levels of anxiety represent risks of MI that may 
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warrant medical attention. Meta-analysis of anxiety as a predictor of death and 
development of CHD compounds the theory of anxiety being an independent predictor 
of CHD and cardiac death (Roest, Martens, Jonge, & Denollet, 2010). Roest et al 
(2010) go on to declare anxiety post MI is associated with a 36% risk of adverse 
cardiac outcomes such as all cause mortality, cardiac death and new cardiac events 
(Roest, Martens, Jonge, & Denollet, 2010). 
Evidence continues to indicate persistent anxiety and depression substantially 
increases the risk of death in patients with ischemic heart disease (Doering, Moser, 
Riegel, McKinley, Davidson, Baker, Meischke & Dracup 2009). After twelve months 
follow-up 23 of 608 (3.8%) of deaths were found to relate to patients with ischemic 
heart disease and persistent depression and anxiety.  
Detailed studies of depression following ACS demonstrate patients with newly 
diagnosed depression symptoms are liable to experience greater poorer health issues 
than those with transient depressive symptoms (Thombs, Ziegelstein, Stewart, Abbey, 
Parakh, & Grace, 2008). Like Doering et al (2009) Thombs et al (2008) identified 
persistent depressive symptoms posed an increased risk of poor health 12 months after 
a diagnosis of ACS, highlighting the importance of assessing patients emotional status 
and psychological history after a cardiac event in order to manage their care and 
support during the weeks and months following their event.  
May, Horne, Carlquist, Sheng, Joy, & Catinella, (2009) report a noticeable influence 
of depression post coronary artery disease (CAD) on heart failure. Patients were 
tracked over several years, from diagnosis to admission for heart failure or death. The 
information provided an insight into the long-term outcomes of patients with heart 
disease. Their study identified 16.4 % of patients presenting with depression following 
CAD diagnosis developed heart failure.  
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Even low levels of depression are found to carry a 50% risk of death within 4 months 
post MI.  Bush, Ziegelstein, Tayback and Richter, (2001) identified the risk exists 
among patients older than 65 years with diabetes and less than 35% left ventricular 
ejection fraction.  
The effect of psychosocial factors in patients with CAD has significant influences on 
increasing depression (Stafford, Berk, & Jackson, 2009). At three and nine months, 
post CAD event,  patients’ with negative illness perceptions demonstrated higher 
levels of depressive symptoms. Older and less socially disadvantaged patients’ 
presented with greater negative beliefs than other subjects involved in the study. 
Monitoring patient social circumstances, particularly older patients, will aid in 
identifying those who need more support during the months following their event. 
Being aware of those most vulnerable will ensure they receive appropriate follow-up 
care. The study had certain restrictions, the authors expressed a concern that patients 
with depression were less likely to participate in the study. It was also noted men and 
women with CAD have different medical, functional and psychosocial profiles. This 
study was predominantly male.   
A review by Naqvi, Naqvi, & Merz,( 2005) highlights the greater prevalence of 
depression in women than men following Myocardial ischaemia. Cognitive behaviour 
therapies showed conflicting results in women. However, women responded to Anti-
depressant therapy more positively than men. Further prospective study is 
recommended to validate this claim. 
The aforementioned theory is compounded by Linke, Rutledge, Johnson, Vaccarino, 
Bittner, Cornell, Eteiba, Sheps, Krantz, Parashar, Merz, (2009) who found women 
with somatic depressive symptoms such as insomnia and lethargy were of higher risk 
of cardiovascular related mortality and events. Implications of the results indicate 
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depression and cardiac mortality need more in depth investigation to understand their 
links. 
Coping mechanisms after an MI are suggested to be symptom specific. Chung, Berger, 
& Rudd, (2008) identified posttraumatic stress disorder (PTSD) in 31% of MI patients 
in their study. Patients who used maladapted, emotional or avoidance coping strategies 
reported increased co-morbidity symptoms such as depression, anxiety, social 
dysfunction and negative illness perceptions (Chung, Berger, & Rudd, 2007). 
Furthermore, interventional treatments such as angioplasty or cardiac surgery resulted 
in increased PTSD symptoms. Chung et al (2007) expressed similar concerns as 
Stafford et al (2009) regarding patients who were in denial of their MI and 
consequently refused to be included in the study. It is possible the effects of PTSD 
could have a greater influence on patients who are in denial of their CHD but 
difficulties in gaining their consent to partake in research projects makes outcomes 
hard to predict. 
In terms of social dysfunction, support and PTSD, Pedersen, Middel and Larsen, 
(2002) identified low perceived social support (LPSS) increases the risk of PTSD and 
depression. Post MI patients who expressed dissatisfaction with their social support 
demonstrated higher levels of anxiety, depression, PTSD and health complaints. 
Neurotic personality traits proved an independent predictor of distress and health 
complaints. Patient’s perceptions of their social support and illness can influence their 
outcomes in the long term.  The ‘Enhanced Recovery in Coronary Heart Disease’ 
(ENRICHD) clinical trial observed the effect of intervention for MI patients with low 
perceived social support (LPSS) depression and anxiety on recurrent MI or subsequent 
death (Writing Committee for the ENRICHD Investigators, 2003). Investigators found 
that although the intervention groups reported improved LPSS and depression, they 
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found no improvement on event free survival compared to the usual care or control 
group of post MI patients (ENRICHD Investigators, 2005). 
A review of non-pharmacological psychological interventions for CHD patients found 
little improvement in patient outcomes although it was noted the studies included in 
the review were of poor quality (Rees, Bennett, West, Smith, & Ebrahim, 2004). The 
review noted slight reductions in anxiety and depression but no effect on mortality or 
life style management. Since the review was published, an increasing amount of 
interest in this subject has delivered significant information, enabling health 
professionals to understand the psychological effects CHD has on patients treated for 
MI, with a view to manage patient care accordingly, reduce re-admission and improve 
patient outcomes. Guidelines on management of anxiety recommend cognitive 
behaviour therapy and, relaxation therapy as an effective evidence based treatment for 
patients with anxiety issues (National Collaborating Centre for Mental Health, 2011). 
Despite the recommendations, the guidelines acknowledge General Practitioners (GP) 
are more likely to offer pharmacological treatments due to limited availability of 
recommended therapies. However, the evidence for depression, anxiety and lack of 
social support is conclusive in its links with mortality in relation to cardiac disease. 
These types of patients are in need of greater support and education at the point of 
diagnosis or identification of risk. Implications of identifying patient issues in the 
early stages post MI can help to influence patient outcomes, quality of life and the risk 
of recurring events.  Further study is necessary to ascertain the most effective way of 
managing these risks and improving availability in order to improve life expectancy. 
2.4 Risk Factors 
The 1950’s saw the recognition of the relationship between lifestyle and heart disease. 
The Framingham Heart Study commenced in 1948. The study observed health and 
social progress of the population of Framingham, Massachusett in America. It is an 
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ongoing study continues to this day. The Framingham study revealed strong links with 
the development of heart disease and risk factors such as cholesterol, diabetes, blood 
pressure, diet, weight, activity, alcohol and smoking (Dawber, Meadors, Moore, 
1951).  The study opened the way forward for scientists to investigate how life style 
influences the development of heart disease with a view to effectively treat and 
educate patients.  In recent years definitive guidelines have been introduced to ensure 
consistent delivery of healthcare and education to people at risk such as the British 
Association of Cardiac Rehabilitation (BACR) (Coats, McGee, Stokes, & Thompson, 
1995).  
2.4.1 Cardiac Rehabilitation 
Comprehensive cardiac rehabilitation programmes are known to reduce patient all 
cause mortality by 27% (Jolliffe, Rees, Taylor, Thompson, Oldridge, & S, 2001). An 
update on Jolliffe et al (2001) original review has also found cardiac rehabilitation 
significantly reduces hospital readmissions within 12 months follow-up of initiating 
event (Heran, Chen, Ebrahim, Moxham, Oldridge, Rees, Thompson & Taylor, 2011). 
Introduction of the National Service Framework (NSF) (Department of Health, 2000),  
set an aim for 85% of eligible revascularised patients to be offered cardiac 
rehabilitation by 2010. The NSF set clear guidance on service delivery based on 
guidelines laid out by the Scottish Intercollegiate Guideline Network (SIGN) (Scottish 
Intercollegiate Guidelines Network, 2002) and the British Association for 
Cardiovascular Rehabilitation (BACR) (Coats, McGee, Stokes, & Thompson, 1995). 
The NSF enabled healthcare workers and Cardiac rehabilitation teams to develop 
effective services for people at risk of heart disease and secondary events. The Cardiac 
Rehabilitation Service at South Bristol models the service accordingly with a view to 
educate patients on the effect of lifestyle issues on CHD and ways to manage relevant 
risk factors accordingly.  
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The Cardiac Rehabilitation patient pathway follows four phases:   
Phase I. In-patient stage: A patient is admitted to hospital with a cardiac event 
such as a Myocardial Infarction (MI), Cardiac Surgery, or PCI for stable or unstable 
angina. Medical management commences and correction of acute disease takes place. . 
Immediate post event: advice and psychological support begin at this stage. The 
Cardiac Rehabilitation Specialist Nurse initiates patient and carer education on the 
wards 
Phase II. Discharge: Telephone or letter contact.  Patients are invited to attend a 
clinic assessment with a view to assess recovery and risk factors, offer advice and 
support. Clinic appointments allow an opportunity for patients to learn more about the 
next phase of Cardiac Rehabilitation. South Bristol resources limit the service to 
hospital and outpatient assessments, but do not allow for home visits as suggested by 
SIGN (2002).  
Phase III. Intermediate outpatient: The patient is invited to attend a 
comprehensive Cardiac Rehabilitation programme within 3 to 6 weeks post event. The 
programme is one day a week and runs for 8 weeks as a rolling programme. Cardiac 
Rehabilitation Specialist Nurses and physiotherapists facilitate the sessions. Each 
session consists of exercise, education of risk factor management and psychological 
support. Service delivery varies for different Cardiac Rehabilitation services 
throughout the UK depending on available resources.  
Phase IV. Long-term maintenance: Patients are encouraged to continue with 
exercise and lifestyle change. Structured phase 4 exercise programmes run by 
instructors trained by the BACR (Coats, McGee, Stokes, & Thompson, 1995) are 
available throughout Bristol. Cardiac Rehabilitation Specialist nurses liaise with 
Bristol City Sports management regarding patient referrals for phase IV exercise 
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groups. Monitoring risk factors continues with Primary Care Teams (PCT) (Scottish 
Intercollegiate Guidelines Network, 2002).  
 
Many clinical studies focus on pharmacological trials for the improvement of CHD 
patient outcomes. The Joint British Society (JBS2) (2005) expressed concerns 
regarding the lack of clinical evidence regarding risk factor management in CHD.  
However, evidence from systematic reviews, meta-analysis and random controlled 
trials have enabled organisations such as the British Association for Cardiac 
Rehabilitation, SIGN and the NSF to lay out guidelines enable health professionals to 
advise and educate patients in secondary prevention. 
The NICE emphasise the importance of secondary education for MI patients, 
highlighting cost effectiveness of risk factor education (National Institute for Health 
and Clinical Excellence, 2007).  
2.4.2 Blood pressure 
NICE (2011) recommend lifestyle management as the first line intervention for 
treatment of hypertension. They recommend blood pressure to be less than 140 
systolic and 90 diastolic. Reductions in blood pressure up to 20 millimols of mercury 
(mmHg) systolic or 10mmHg diastolic significantly reduces risks of mortality from 
strokes or heart disease (Lewington, Clarke, Qizilbash, Peto, & Collins, 2002). The 
evidence is particularly relevant to middle age 40 to 49 years, with a twofold reduction 
in risks. NICE (2011) recommend relaxation is included in lifestyle management of 
hypertension. Collated evidence demonstrates a reduction of at least 10mmHg in 
systolic blood pressure among 33% of hypertensive patients practising relaxation once 
a week. Ongoing investigations into the effect of stress and relaxation on nitrous oxide 
(NO) levels have, to date, revealed increased NO levels are associated with relaxation 
Fiona Barnard                    MSc Cardiac Rehabilitation Dissertation.                September 2011 
 
19 
 
(Dusek & Benson, 2009). The effect NO has on smooth muscle in the arteries is 
thought to explain reductions in blood pressure for those who practice relaxation on a  
regular basis. The authors claim patients medication has been reduced as a result of 
continued relaxation. Further evidence is necessary to support this claim and identify 
relaxation as an independent predictor of blood pressure reduction. The study is 
ongoing, but current results highlight the effectiveness of relaxation as not only a 
physical benefit, but also a cost effective one.  
2.4.3 Obesity 
 Obesity links closely to cardiovascular disease. Increased weight relates to increased 
adipose tissue and total blood volume. Resulting in a higher cardiac output, poor left 
ventricular (LV) function, reduced adipose tissue perfusion and increased peripheral 
vascular resistance (Poirier, Giles, Bray, Hong, Stern, Pi-Sunyer et al, 2006). Neter, 
Stam, Kok, Grobbee and Geleijnse, (2003) describe associations of weight and blood 
pressure. Obesity subjects presented with over activity in the renin, angiotensin and 
aldosterone system causing increased renin activity and higher concentrations of 
aldosterone, thus an increase in blood pressure. Their study reported significant 
reductions in blood pressure when subjects lost weight. A loss of 1 Kilogram of 
weight equates to a reduction of 1.05 mmHg in systolic and 0.92 mmHg diastolic 
blood pressure. Obesity as an independent risk for CHD is also contributory to other 
factors such as diabetes and hypertension, which is more prevalent in overweight 
subjects (Poirier, Giles, Bray, Hong, Stern, Pi-Sunyer et al, 2006).  
Clinical evaluation of obese patients outcomes following acute coronary events 
revealed unexpected outcomes (Eisenstein, et al., 2005). Although very obese subjects 
were found to have poorer intermediate survival rates, so were patients with a healthy 
body mass index (BMI). Patients classed as overweight and obese had better 
intermediate survival rates during the 30, 90 day and one year study period. The study 
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found death and MI rates similar for all groups, but recommended further investigation 
into outcomes for healthy weight patients. However, Murphy, MacIntyre, Stewart, 
Hart, Hole, & McMurray, (2006) examined long term consequences of obesity over a 
20 year period. They conclude obesity is associated with a broad range of fatal and 
non-fatal cardiovascular events. From their study results indicated 9 additional 
cardiovascular deaths and 36 additional hospital admissions per 100 affected middle 
aged men over 20 years. With obesity becoming an increasing problem in the UK, 
Murphy et al predict the problem will only increase over the next 20 years. NICE 
(2006) have been striving to change public attitudes towards obesity by setting 
guidelines for schools, communities and health professionals to educate and motivate 
people into adopting a healthier approach to life. 
2.4.4 Diet 
In response to Department of Health concerns, NICE (2010) produced guidelines for 
prevention of CVD at population level. Recommendations are for supportive litigation to 
encourage food manufacturers to adjust marketing strategies in order to reduce salt and fat 
content in products thus contributing to reduction in general public salt and fat intake.  
NICE (2010) acknowledge associations of salt with blood pressure. General salt intake 
and blood pressure has increased in the UK since initial introduction of guidelines in 1994 
recommending the daily salt intake should amount to less than 6 grams per day.  Evidence 
has led to the belief that higher sodium levels result from reabsorbtion in the renal system 
and stands as an independent response of blood pressure to salt in hypertension (Chiolero, 
Maillard, Nussberger, Brunner and Burnier, 2000). The effect of increased sodium intake 
was found to have an impact on the neuropathic system and its regulation of the 
cardiovascular system (Coruzzi, Parati, Brambilla, Brambilla, Gualerzi, Novarini et al, 
2005).  Their study, although small (n= 34) identified a correlation between impairment of 
parasympathetic cardiac control and an increase in of salt sensitivity. As part of a study 
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into high protein, low carbohydrate and high mono-unsaturated fat diet in type 2 diabetics, 
Parker, Noakes, Luscombe & Clifton, (2002) evidence revealed decreased LDL levels, 
weight, abdominal fat and blood pressure. Female response produced better results with a 
high protein diet whereas men achieved the same results on a low protein diet. 
Recommendations post MI suggest a Mediterranean style diet, which includes oily fish, 
fruit, plant oils, more, bread and less meat and dairy products, as a means to prevent 
secondary events ( National Institute for Health and Clinical Excellence, NICE, 2007). 
Low carbohydrate diets increase HDL levels and improve ratio of total cholesterol to 
HDL, whereas the Mediterranean diet influences reduction in LDL levels. Furthermore, 
low carbohydrate and Mediterranean diet have produced more favourable results than low 
fat diets in respect of weight loss, improving metabolic effects and glycaemia control 
(Schwarzfuchs, Henkin, Shahar, Witkow, Greenberg, Golan et al, 2008).   
2.4.5 Exercise 
 Ballor and Poehlman (1992) compared aerobic training, resistant training and 
sedentary groups for fitness and metabolic outcomes. They established resistant 
training showed improvements in fitness but aerobic exercise had a significantly better 
effect on metabolic rate and peak oxygen consumption (VO2) resulting in increased 
fitness and improved lipid levels. Wosornu, Bedford and Ballantyne, (1996) found 
combining aerobic exercise and resistant exercise resulted in improved fitness levels, 
increased weight loss and reduced body fat compared to aerobic exercise alone.  
Further evidence supporting their study agrees combining regular aerobic and 
strengthening exercises has a positive effect on HDL levels and results in a significant 
decrease in total cholesterol, LDL and triglycerides (Moghadam, Tavakol, Hadian, 
Bagheri, Jalaei, 2009). Their study, comparing aerobic only exercise with combined 
strength and aerobic protocols, concludes an element of strengthening or resistant 
exercise can have beneficial results for CHD patients. The effect aerobic exercise has 
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on blood pressure primarily reduces systemic vascular resistance, involving the 
sympathetic nervous and renin angiotensin systems, therefore influencing blood 
pressure reduction. Trial results show resting blood pressure reduced by 6.9mmHg 
systolic and 4.9 mmHg diastolic through aerobic exercise (Fagard and Cornelissen, 
2007). Moghadam et al (2009) conducted their trial on CABG patients over a three 
month period. However, exercise will assist in maintained reduction in triglyceride 
levels and increased HDL levels providing weekly regimes of brisk walking or jogging 
are consistent (Durstine, Grandjean, Cox, Thompson, 2002).  
2.4.6 Alcohol 
NICE (2007) recommend alcohol consumption should be limited, for post MI patients, 
to no more that 3 to 4 units per day for men, 2 to 3 units for women. The daily 
recommendation is set as an intention to steer people away from binge drinking. 
Frequent alcohol consumption at a moderate rate of 3 to 4 days per week is associated 
with lower risks of myocardial infarction (Mukamal, Jensen, Grønbæk, Stampfer, 
Manson, Pischon & Rimm, 2005). Their study of men and women over the course of 
eight years, found positive effects on HDL, fibrinogen and haemoglobin A amongst 
those who drank a moderate amount of alcohol over a 3 to 7 day period.  Previous 
review of studies into alcohol confirmed light consumption of alcohol increases HDL, 
reduces triglycerides and also has beneficial effects on the development of 
atherosclerosis through enhancement of insulin sensitivity (O’Keefe, Bybee, & Lavie, 
2007). Their review identifies heavy alcohol use results in declining ejection fraction 
and progressive left ventricular hypertrophy leading to alcohol induced 
cardiomyopathy. Furthermore, they suggest alcohol is known to be high in calories 
and can lead to abdominal obesity, which is associated with reduced HDL levels.  
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2.4.7 Smoking 
It was not until the 1960’s that smoking and links with heart disease became apparent. 
One study identified only 2.5% of male participants with atherosclerosis were non-
smokers (Juergens, Barker, Hines, 1960). They identified smoking to be a contributing 
factor to arterial thrombosis in atherosclerosis. Smoking continues to be a main cause 
of preventable premature death and morbidity in the UK (National Institute for Health 
and Clinical Excellence Guidance Committee, 2008). Smoking is reported to cost the 
NHS over £1 billion pounds per year through related illness. Research identified 
smokers had a 50% increase in atherosclerotic disease compared to non-smokers 
(Howard, Wagenknecht, Burke, Diez-Roux, Evans, McGovern, et al, 1998). Further to 
this, the study found increased levels, 25%, of progressive atherosclerosis in non-
smokers who were exposed to a smoking environment.  In support of Howard et al 
(1998) findings, Law, Morris and Wald, (1997) identified exposure of non-smokers to 
environmental smoke increases platelet aggregation resulting in a 34% increase risk of 
ischaemic heart.  Combine smoking or passive smoking with other CVD risk factors 
and it is plain to understand Department of Health concerns on the needless costs to 
the health service and are currently investing in campaigns to encourage smoking 
cessation.  
2.4.8 Anxiety, Depression and Risk Factors 
Certain behaviours leading up to CVD events are associated with psychological 
distress. Studies into post MI patient outcomes are enabling health professionals to 
gain a better understanding in order to improve patient journeys following their 
cardiac event (table 2). 
Hamer, Molloy, & Stamatakis, (2008) identified behavioural activities were strongly 
associated with psychological distress and the lead up to CVD events, predominantly 
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smoking and lack of exercise. Hypertension and C - reactive protein (CRP) levels 
posed a moderate risk. 
After an MI, anxiety alone has an influence on patients’ adherence to risk reducing 
advice (Kuhl, Fauerbach, BushRoy, & Ziegelstein, 2009). Kuhl et al (2009) 
investigated post MI anxiety levels and found higher levels were linked with patients 
who did not adhere to advice, smoking cessation in particular. However, these patients 
were more likely to carry supplies (sub-lingual nitro-glycerine). The author speculates 
patients with higher anxiety levels may be concerned about ongoing chest pain or feel 
less anxious by carrying supplies.  
Incidental information from Kuhl et al (2009) revealed patients who live alone were 
more likely to have elevated anxiety levels at four months post MI. Social 
circumstances should be of prime consideration for health professionals assessing 
patients during initial admission. Their study found no relationship with patient length 
of stay in hospital but noted female gender, age, depression and hypertension were 
more likely to have higher anxiety levels at baseline over time. 
An early study of patients’ experiences and their perceptions found the more negative 
perceptions are, the less likely they are to return to work, recreational activities and 
social interaction (Petrie, Weinman, Sharpe, & Buckley, 1996). Sexual dysfunction 
increased in patients with stronger illness identity. Cardiac rehabilitation attendance 
was better for patients who believed their illness to be curable or controlled.  
The Manchester Heart Centre is currently conducting extensive studies into the 
outcomes of patients re-admitted to hospital following PPCI for STEMI. The main 
point of   interest is re-admission rates for PPCI patients. Published interim results 
note readmitted PPCI patients report receiving insufficient information or follow-up 
post MI (Iles-Smith, McGowan, Rogers, Fath-Ordoubadi, Dickens, & Deaton, 2009). 
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The study identified negative perceptions of patients such as anger and uncertainty of 
symptom recognition along with a loss of confidence.  Further analysis of the 
Manchester study revealed Global Registry of Acute Cardiac Events score (GRACE) 
to be higher in PPCI patients at baseline along with HAD scores indicating  better 
clinical outcomes (McGowan, Iles-Smith, Dickens, Campbell, Rogers, & Fath-
Ordoubadi, 2011). The COURAGE trial incorporated a comprehensive nurse led 
lifestyle management programme into their study where patients received counselling 
and lifestyle advice at six monthly intervals until the end of the study (Maron, Boden, 
Weintraub, Calfas, & O’Rourke, 2011).  The overall results conclude time spent with 
patients, regardless of their treatment, results in improvements of lifestyle and 
modification of risk factors. 
Table 2: Literature relating to risk factors and lifestyle management in cardiac disease 
Author  
& Year 
Study Title Group  
Type 
Study  
Type 
Assessment Tool Size (n) Findings 
Hamer  
et al, 2008 
Psychological 
Distress as a 
Risk Factor  
for Cardio- 
vascular Events 
Pre CVD events Prospective 
research 
(average of 7 
years to point 
of CVD 
event) 
Scottish Health 
Survey (SHS), 
General Health 
Questionnaire, 
Behavioural and 
patho-physiology 
risk factors 
6,576 CVD risk  increased in relation 
to psychological distress in 
age and sex. Behavioural 
factors explained the largest 
proportion of variance. Patho-
physiological factors account  
for a modest amount. 
Iles-Smith  
et al, 2009 
A qualitative study 
of the experiences 
of MI patients who 
represent post-
PPCI 
PPCI Qualitative 
study 
Interviews 17 A great deal of uncertainty, 
anger and anxiety exits in 
relation to symptom 
recognition. Loss of 
confidence and inability to 
make sense of symptoms 
featured highly. Patients 
attempted to construct illness 
events and reported receiving 
insufficient information or 
follow-up post-primary PCI. 
Kuhl et al,  
2009 
Relation of 
Anxiety and 
Adherence to Risk-
Reducing 
Recommendations 
Following MI 
MI Prospective 
research (MI 
to 4 months 
post event) 
Beck Anxiety 
Inventory 
278 High anxiety levels 4 months 
post MI resulted in worst 
adherence to exercise, stress 
management, increasing 
socialisation and smoking 
cessation in particular. Better 
adherence to carrying supplies. 
High anxiety levels 4 month 
post MI in patients living 
alone.  
Maron et al 
COURAGE, 
2007 
Optimal Medical 
Therapy with or 
without PCI for 
Stable CAD Randomized 
Clinical Trial 
PCI v Medical 
Treatment 
2,287 PCI did not reduce the risk of 
death, myocardial infarction, 
or other major cardiovascular 
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Stable CAD events when added to optimal 
medical therapy. 
McGowan et 
al, 2011 
The relationship 
between 
psychological 
factors and 
impaired health-
related quality of 
life post STEMI 
STEMI 
PPCI v 
Thrombolysis 
Prospective 
cohort 
Charlson Co 
morbidity Index. 
Illness 
perceptions. 
Hospital Anxiety 
and Depression 
Scale. 
Health-related 
quality of life 
(SF-36). 
SF-36 Physical 
Component 
Score 
385 Higher GRACE scores for 
PPCI group. No differences in 
LV function. Thrombolysis 
patients had more co morbid 
illness. Total HADS score was 
significantly higher in the 
PPCI vs Thrombolysis group 
at baseline. Raised levels of 
depression and anxiety 
predicted impairment in 
health-related quality of life at 
6 months post-STEMI, 
regardless of mode of 
treatment. 
Petrie et al,  
1996 
Role of patients' 
view of their 
illness in 
predicting return to 
work and 
functioning after 
MI 
MI Prospective 
trial 
Illness Perception 
Questionnaire. 
Sickness Impact 
Profile. 
Four Item 
Sexual 
Functioning 
Scale. 
143 Attendance at the 
rehabilitation course related to 
stronger belief, during 
admission, that illness could 
be cured or controlled. Return 
to work within six weeks was 
predicted by perception of 
illness lasting a short time and 
having fewer consequences for 
the patient. Patient belief that 
heart disease would have 
serious consequences, related 
to later disability in work 
around the house, recreational 
activities, and social 
interaction. Strong illness 
identity significantly related to 
greater sexual dysfunction at 
both three and six months. 
 
Study results indicate a need to assess patient perceptions and commence early 
education following their MI to ensure they have appropriate understanding of their 
condition and long term implications.  
2.5 Pre-discharge Information 
Motivating patients to change their lifestyles has proved quite a challenge to health 
educators and providers. Information and education plays an important part in patient 
outcomes in the long term after their MI. Many studies have investigated the most 
effective way to influence patients to examine their lifestyle and make appropriate 
adjustments to improve their quality of life and reduce mortality rates (table 3). 
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Secondary prevention and education often commences during patients’ hospital 
admission following their cardiac event. Duryee, (1992) reviewed 21 studies 
conducted between 1975 and 1989 regarding in-hospital education for MI patients. 
Overall results highlighted risk factors as their primary concern. The level of anxiety 
did not affect patients ability to learn new information, especially regarding activity. 
The effect of inpatient education stimulated some lifestyle change post discharge, 
particularly smoking cessation and activity. In terms of teaching methods, the review 
found audiovisual methods were as effective as one to one patient teaching. Evidence 
in general demonstrates that early education has a positive effect on patients’ 
perceptions and lifestyle management.  
The effectiveness of various levels of secondary prevention can influence patient all 
cause mortality (Auer, Gaume, Rodondi, Cornuz, & Ghali, 2008). Trained health care 
professionals following global systems of care, such as critical pathways, can 
significantly reduce mortality for ACS patients in the long term by providing direct 
counselling and education to the patient while in hospital. However, Auer, et al (2008) 
admit their study is not definitive and further research is needed to examine which 
components of secondary interventions produce the greatest benefits to patients and 
health services. 
In-hospital complications were found to rise for each unit increase on the ‘Illness 
perception’ score (Cherrington, Moser, Lennie, & Kennedy, 2004). Anxiety and 
depression did not appear to affect the incidence of complications prior to patients 
discharge. However, post MI complications correlated with negative illness 
representations. Huffman, Smith, Blais, Januzzi, & Fricchione, (2008) also examined 
the effect of anxiety on patients post MI to identify independent associations with in-
hospital complications. Their study of 110 subjects concluded post MI anxiety is 
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significantly associated with in-hospital cardiac complications. They consider it an 
independent predictor of such events.  
Further evidence supporting Huffman et al (2008) suggest higher anxiety levels in-
hospital post MI can pose a physical risk of  arrhythmic and ischemic complications 
(Moser, Riegel, McKinley, Doering, An, & Sheahan, 2007). Mosers continued studies 
revealed the impact of one to one nursing intervention prior to discharge enabled 
patients to feel in control of their symptoms and demonstrated significant reduction in 
post MI anxiety levels (Moser, McKinley, Doering, Meischke, Pelter, Davidson, Baker 
& Dracup, 2010).  
Timing of patient education and interventions are key to their long term outcomes. The 
introduction of PPCI treatments for STEMI has led to patients being discharged 
sooner. Concerns are being raised regarding time allowed for patient education prior to 
discharge and the effect on their recovery. Fredericks, (2009) examined the effect of 
timing education to patients post coronary artery bypass graft. The findings revealed 
no significant difference to patients outcomes whether given individualised education 
prior to or post discharge. However, patient anxieties were identified to be higher in 
the 24 hours prior to discharge than at any time during the three weeks following 
discharge home. The implications of this study suggest management of patients 
anxiety should be a priority before they are discharged home. However, CABG 
patients are often elective and have had time to prepare for their admission, this may in 
turn impact on their anxiety levels post surgery. MI patients have no pre-emption of 
their circumstances Fredericks study may produce different outcomes with MI 
patients. Little guidance is available to suggest how anxiety management is best 
delivered to MI patients. The BRI cardiac rehabilitation specialist nurses aim to see all 
MI patients on the wards prior to their discharge. Each visit takes approximately an 
hour. The time is used to ensure the patient understands what a heart attack is and 
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what treatment they received, including advice on medication and its effects. The 
patient is advised about building up activities and managing specific risk factors over 
the following weeks.  
Early intervention can result in positive outcomes as Petrie, Cameron, Ellis, Buick, & 
Weinman, (2002) identified. Not only did patients demonstrate positive changes in 
their views and misconceptions of their MI, but they also returned to work sooner and 
presented with fewer angina symptoms at three months post event. The uptake of 
Cardiac Rehabilitation, however, remained the same for the intervention and control 
groups. 
Smoking cessation is a tough challenge, McBride, Emmons, & Lipkus, (2003) 
examined the most appropriate ‘Teaching Moment’ for health behaviours. The most 
favourable results related to advising patients to stop smoking. Their findings 
suggested pregnancy and in hospital smoking advice resulted in a high percentage of 
smokers successfully stopping, up to 78%. However, visits to a clinic or abnormal test 
results did not produce such favourable results. The study suggests educating patients 
who smoke when admitted to hospital for an acute event may contribute towards a 
more favourable outcome. 
Table 3: Literature relating to pre-discharge information for Cardiac Patients 
Author 
& Year 
Study Title Group 
Type 
Study Type Assessment 
Tool 
Size (n) Findings 
Auer et 
al, 2008 
Efficacy of In-
Hospital 
Multidimensional 
Interventions of 
Secondary 
Prevention After 
ACS 
ACS A 
Systematic 
Review and 
Meta-
Analysis 
Systematic 
review 
14 
Studies 
Before-after studies suggest reduced 
mortality. Interventions including 
provider or system-level intervention 
suggested reduced mortality compared 
with patient-level only interventions. 
Cherrin
gton et 
al, 2004 
Illness 
Representation 
After AMI: 
Impact On In-
Hospital 
Recovery 
MI with 
PCI 
Prospective 
Correlation 
Illness 
Perception 
Questionnaire. 
Spielberger 
State Anxiety 
Inventory. 
Beck 
Depression 
Inventory. 
49 Negative illness perceptions increase in 
hospital complications. 
Anxiety and depression have no 
significant effect. 
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Interviews. 
Duryee, 
1992 
The efficacy of 
inpatient 
education after 
MI 
MI Literature 
review 
None 
specified 
21 
studies 
between 
1975 & 
1989 
Risk factors were patients primary 
concern. Anxiety did not affect patients 
ability to learn. Inpatient education 
stimulated some lifestyle change post 
discharge, particularly smoking cessation 
and activity. Audio visual methods were 
as effective as one to one patient 
teaching. 
Frederic
ks, 2009 
Timing for 
delivering 
individualized 
patient education 
intervention to 
CABG patients 
CABG Randomized 
control trial 
(3 weeks) 
Patient 
Learning 
Needs Scale, 
15-item 
Knowledge 
Inventory, 
Revised 
Heart Failure 
Self-Care 
Behaviour 
scale (RSCB), 
Symptom 
Inventory, 
State Anxiety 
Scale 
 
172 No significant outcomes in timing of 
education whether pre or post discharge. 
Patient anxiety levels are significantly 
higher during the 24 hours prior to 
discharge. 
Huffma
n et al, 
2008 
Anxiety, 
independent of 
depressive 
symptoms, is 
associated with 
in-hospital 
cardiac 
complications 
after AMI 
MI Prospective 
study 72 
hours post 
MI 
Beck Anxiety 
Inventory 
Beck 
Depression 
Inventory-II 
Interviews 
110 MI anxiety was significantly associated 
with in-hospital cardiac complications. 
Post-MI anxiety remained an 
independent predictor of cardiac 
complications 
McBride 
et al, 
2003 
Understanding 
the potential of 
teachable 
moments: the 
case of smoking 
cessation 
Smokers Systematic 
review 
Literature 
review 
160 
Studies 
Cessation rates associated with 
pregnancy, hospitalization and disease 
diagnosis were high (10–60 and 15– 
78%, respectively), whereas rates for 
clinic visits and abnormal test results 
were consistently lower (2–10 and 7–
21%, respectively). 
Moser et 
al, 2007 
Impact of 
Anxiety and 
Perceived 
Control on In-
Hospital 
Complications 
After AMI 
MI Prospective 
research 
Brief 
Symptom 
Inventory 
536 Anxiety during the in-hospital phase of 
AMI is associated with increased risk for 
in-hospital arrhythmic and ischemic 
complications independent of traditional 
socio-demographic and clinical risk 
factors. The combination of high anxiety 
and low perceived control is associated 
with the highest risk of complications 
Moser et 
al, 2010 
The impact on 
anxiety and 
perceived control 
of a short one-on-
one nursing 
intervention 
designed to 
decrease 
treatment seeking 
delay in people 
with CHD 
Coronary 
Artery 
Disease 
Randomized 
control trial 
Multiple 
Affect 
Adjective 
Checklist 
3,522 Interventions in which cardiac patients 
directly confront the possibility of an 
acute cardiac event do not cause anxiety 
if they provide patients with appropriate 
strategies for managing symptoms. 
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Petrie et 
al, 2002 
Changing Illness 
Perceptions After 
MI 
MI Early 
Intervention 
Randomized 
Control 
Trial 
(pre-
discharge & 
3 months) 
Illness 
Perception 
Questionnaire 
65 Intervention caused significant positive 
changes in patients’ views of their MI. 
The intervention group reported being 
better prepared for leaving hospital and 
subsequently returned to work faster 
than the control group. 3-month follow-
up,  
the intervention group reported a 
significantly lower rate of angina 
symptoms than control subjects. There 
were no significant differences in 
rehabilitation attendance between the  
two groups 
 
It is evident that patient education is important prior to discharge from hospital 
following an MI. Study results demonstrate faster return to work, compliance with 
smoking cessation, fewer related symptoms and generally more positive outcomes. It 
is also vital that education continues after discharge to ensure better outcomes for 
patients. The time patients spend with health professionals at the earliest opportunity 
following their cardiac event can be invaluable to their outcomes in the longer term. 
2.6 Comparing PPCI to Thrombolysis 
Before the introduction of PPCI, patients from the Avon, Gloucester, Wiltshire and 
Somerset areas were often transported to the BRI for rescue PCI if thrombolysis failed 
pre-admission or at their local emergency department. The success of PPCI on patient 
outcomes has resulted in the procedure being routine treatment for MI patients Bristol 
and the UK in general (table 4). 
Table 4: Literature comparing thrombolysis and PPCI 
Author & 
Year 
Study Title Group 
Type 
Study Type Assessment 
Tool 
Size (n) Findings 
COURAGE
, 2007 
Optimal 
Medical 
Therapy with 
or without 
PCI for 
Stable CAD 
Stable 
CAD 
Randomized 
Clinical Trial 
PCI v 
Medical 
Treatment 
2,287 PCI did not reduce the risk of death, 
myocardial infarction, or other major 
cardiovascular events when added to 
optimal medical therapy. 
Every et al, 
1996 
A 
Comparison 
of 
Thrombolytic 
Therapy with 
PCA for 
AMI 
MI Retrospective 
study 
Patient data 1050 PPCI 
2095 
Throm- 
bolysis 
Total= 3145 
There was no significant difference in 
mortality during hospitalization or 
long-term follow up between patients 
in the thrombolytic and primary 
angioplasty group. Rates of 
procedures and costs were lower 
among the thrombolytic group both at 
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the time of hospital discharge and 
three years follow-up. 
Keeley, 
Boura, & 
Grines, 
(2006) 
Comparison 
of primary 
and 
facilitated 
percutaneous 
coronary 
interventions 
for ST-
elevation 
myocardial 
infarction: 
quantitative 
review of 
randomised 
trials 
STEMI Clinical  
Trial 
Patient  
Data 
4504 Facilitated patients had higher 
mortality, re-infarction, in-stent 
restenosis, bleeding and strokes than 
PPCI and is not recommended. 
PAMI 
Study 
Group, 
1993 
A 
Comparison 
of Immediate 
Angioplasty 
with 
Thrombolytic 
Therapy for 
AMI 
STEMI Randomized 
clinical trial 
Randomized 
allocation 
395 Compared with tPA therapy for acute 
myocardial infarction, immediate 
PTCA reduced the combined 
occurrence of nonfatal re-infarction or 
death, was associated with a lower 
rate of intracranial haemorrhage, and 
resulted in similar left ventricular 
systolic function. 
PAMI I 
Study 
Group, 
1999 
Long-Term 
Outcome 
After PPCI: 
(PAMI-I) 
Trial 
PPCI Randomized 
clinical trial 
PPCI or 
Throm-
bolysis for 
STEMI 
395 At two years, primary angioplasty had 
less recurrent ischemia, lower re-
intervention rates and reduced hospital 
readmission rates. Angioplasty is 
independently predictive of a 
reduction in death, re-infarction or 
target vessel revascularization. 
 
In hospital deaths were reduced by over 50% for STEMI patients treated with PPCI 
during initial trials (The Primary Angioplasty in Myocardial Infarction Study Group, 
1993). Furthermore, recurrent MI, death and intra-cranial bleeds were reduced during 
the six months following the initial event. Left ventricular function remained equal 
between the two groups. Later reports revealed PPCI to have favourable results in 
terms of re-infarction, readmission, re-intervention and death over a two year period 
compared to thrombolysis (The Primary Angioplasty in Myocardial Infarction I Study 
Group, 1999).  
Clinical trials comparing PPCI to facilitated patients receiving PCI following 
thrombolysis produced definitive results (Keeley, Boura, & Grines, 2006). Facilitated 
PCI involved STEMI patients receiving thrombolysis prior to PCI with the intent to 
improve coronary patency.  Thrombolysis resulted in increased deaths and reinfarction 
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compared to PPCI. Furthermore, patients were more likely to present with restenosis 
of the treated artery. Patients were also more likely to bleed or suffer a stroke 
following the procedure. The study does not recommend the use of facilitated PCI in 
any circumstance.  
The Myocardial Infarction Triage and Intervention Project (MITIP) involved a Cohort 
of 12,331 patients admitted to Seattle Hospitals between 1988 and 1994. A 
comparison study of patients treated with PPCI or thrombolysis was implemented on 
the strength of the MITIP data (Every, Parsons, Hlatky, Martin, & Weaver, 1996). 
They found no significant differences between the two treatments in terms of mortality 
in hospital or during the three years follow up. They did find, however, that the PPCI 
treatment was more costly and thrombolysis patients required fewer procedures during 
the three year follow-up. Costs remain to be a contention in terms of NHS treatments 
for MI patients. The Heart Improvement guide (McLenachan, Machin, & Marley, A 
Guide to Implementing Primary Angioplasty, 2009) addresses this issue and suggests 
patients undergoing Thrombolysis are inevitably readmitted for PCI within six months 
of their initial event, whereas PPCI brings the inevitable procedure forward. The guide 
suggests the introduction of PPCI will reduce costs in the long term. 
The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation 
trial (COURAGE) (2007) compared outcomes for patients with stable CAD treated 
with medication only or PCI with medication. The results to date indicate no 
significant changes to the risk of death, MI  or other major cardiovascular events when 
PCI was added to optimum medical therapy. However, PCI patients had a lower 
incidence of treatment for recurring angina symptoms (21% vs. 32.6%) during the first 
36 months. The difference evened with medically treated patients after that time span.  
This poses the question of how much emphasis physicians place on lifestyle and long-
term management. Patients treated medically may be more aware of their chronic 
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disease and so are more inclined to make lifestyle changes, whereas, as Astin et al 
(2008b) found, PCI patients may believe their PCI intervention equates to a cure for 
their disease and become complacent about modifying their lifestyle.  
2.7 Length of Stay 
The introduction of PPCI has resulted in patients spending less time in hospital.  
The average stay for STEMI patients treated through thrombolysis was 5 days. 
Hosbond, Hansen, & Thomsen, (2007) concluded it safe to discharge patients within 
four days post PPCI for STEMI. They identified death and rehospitalisation was very 
low within 1 year of the initiating treatment. Several studies have addressed length of 
stay following treatment for STEMI (table 5), Laarman & Dirkson, (2010) reviewed 
evidence regarding PPCI and thrombolysis patient discharge. They conclude PPCI 
patients are safely discharged at three days post event but emphasise provision of costs 
should be made for a minority of patients who may develop adverse events three or 
four days post event. The development of  a nurse led PPCI protocol (appendix A) has 
ensured PPCI patients are safely discharged in Bristol after 48 hours (Oriolo & 
Tagney, 2011) with the involvement of specialist nurse practitioners.  
One Norwegian study identified a shorter hospital stay predicted higher depression 
levels at 18 months in MI patients (Hanssen, Nordrehaug, Eide, Bjelland, & Rokne, 
2009). 
Table 5: Literature relating to length of hospital stay. 
Author & 
Year 
Study Title Patient 
Group 
Study Type Assessment 
Tool 
Size (n) Findings 
Astin et al, 
2008a 
The information 
needs of patients 
treated with primary 
angioplasty for heart 
attack: An 
exploratory study 
PPCI Qualitative 
methodology 
Interviews 29 Health information provision was 
satisfactory but improved by closer 
matching of patients’ preferences 
with provision. Shortened hospital 
stay, rapid throughput and emotional 
shock influenced ability to absorb 
information making optimum timing 
for health information delivery 
variable. 
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Astin et al, 
2008b 
Primary angioplasty 
for heart attack: 
mismatch between 
expectations and 
reality 
PPCI Qualitative 
study 
Illness 
Perception 
Questionnaire, 
Interviews 
29 Patients’ experiences were 
characterized by a mismatch 
between their expectations and 
reality. Questionnaire data supported 
the notion that they had trouble in 
‘making sense’ of their condition in 
a coherent way. They tended to see 
their condition as ‘acute’ rather than 
‘chronic’ and their treatment as 
curative. 
Hansen et 
al, 2007 
How do early 
discharge after 
primary PCI impact 
on post-discharge 
mental stress and 
perception of health. 
PPCI Prospective 
qualitative 
study 
Interviews 
Likeart Scale 
(not specified) 
60 93% found hospital stay appropriate. 
95% felt physically and mentally 
ready for discharge. 
85% considered their condition not 
serious by day 2. 
22% felt more ‘sad’ at 3 months. 
87% considered their condition good 
at 3 months. 
78% found the 3 day phone call 
useful. 
Hanssen et 
al, 2009 
Anxiety and 
depression after 
acute myocardial 
infarction: an 18-
month follow-up 
study with repeated 
measures 
and comparison 
with a reference 
population 
MI Prospective 
cohort. 
Hospital 
Anxiety and 
Depression 
Scale. 
 
288 At baseline, AMI patients were more 
anxious, but not more depressed, 
when compared with reference 
population. At 3–18 months, AMI 
patients’ levels of anxiety and 
depression were no higher than 
levels in the reference population. 
Anxiety and depression at baseline 
and after 3 months were the best 
predictors of anxiety and depression 
after 18 months. Complications, bed 
days and lifestyle improvement 
significantly predicted depression 
after 18 months. 
Hosbond et 
al, 2007 
Do early discharge 
after primary PCI 
result in a higher 
rate of death or re-
hospitalization? 
PPCI Prospective 
follow up 
Non specified 79 Very low rate of death and 
rehospitalisation at 1 year. Safe to 
discharge patients within 4 days of 
PPCI post STEMI. 
Laarman & 
Dirkson, 
2010 
Early discharge 
after primary 
percutaneous 
coronary 
intervention 
PPCI Literature 
review 
None 
specified 
None 
specified 
The risk score reliably identifies a 
large group of patients at very low 
risk, who may safely be discharged 
early after primary angioplasty. This 
approach would also result in a 
substantial cost saving. 
Oriolo & 
Tagney, 
2011 
PPCI: Is there a role 
for the ACS 
Advanced Nurse 
Practitioner? 
ACS Prospective 
Audit 
Length of 
Stay 
274 Patients seen and discharged solely 
by the advanced nurse practitioner, 
the average LOS decreased from 4.4 
days to 2.0 days. 
 
The speed of throughput can result in patients feeling they have not received enough 
information specific to their individual condition. Astin, Closs, McLenachan, Hunter, 
& Priestley, (2008b) interviewed 29 patients to evaluate their experience of post PPCI 
information. Patients general consensus was overall satisfaction. However, a common 
need was expressed for specific information relating to recurrence, myocardial 
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damage, activity, diet and medications. Astin et al (2008a) conclude the speed of 
throughput and shock experienced by patients can limit their ability to absorb 
information. They recommend staged information individualised to patient needs and 
home visits may improve patients experience and knowledge of their disease 
management. 
Further research by Astin from the same group size revealed PPCI patients 
experiences to be positive although assessments demonstrated emotional shock 
exacerbated by their speedy treatment and discharge from hospital. The qualitative 
information collected from patients highlighted a mismatch between their experience 
and expectations. Patients did not fully understand their condition coherently and 
failed to view their CHD as a chronic condition, but rather felt it was an acute episode 
and they were now cured (Astin, Closs, McLenachan, Hunter, & Priestley, 2008b). 
A small Danish study implemented a nurse led follow up programme for rapid 
discharge of PPCI patients (Hansen, Hosbond, & Thomsen, 2007). They followed up 
patients with phone calls, nurse led clinics and recommended a Cardiac Rehabilitation 
programme. The majority of feedback was positive. Patients felt their length of stay, 
being an average of 4 days or less was appropriate and felt positive about their 
condition. Of 60 patients, 22% felt ‘sad’ three months following their MI. The study 
mentioned 85% of patients considered their condition not serious at all by the second 
day post event. Although a positive response, one could question how complacent the 
patient feels about their condition. Hansen et al (2007) does not expand on this point.  
The literature demonstrates the ongoing issues patients and healthcare professionals 
must negotiate when considering outcomes following the incidence and treatments for 
MI patients. The links between anxiety, depression, mortality and re-admissions can 
lead to increasing distress to the patient and prove costly to health services. The 
introduction of new treatments are shown to improve patient admission times, 
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therefore, more efficient use of hospital beds. However, the effect these treatments 
have on patient experiences should not be overlooked. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fiona Barnard                    MSc Cardiac Rehabilitation Dissertation.                September 2011 
 
38 
 
3. Methodology 
3.1 Participants 
This retrospective review involves patients admitted to the BRI from April 2004 up to 
March 2010. The selected patients were diagnosed with a STEMI and treated with 
either Thrombolysis or PPCI. Patient diagnosis is defined through assessment of 
symptoms and ECG. Thrombolysis, such as Tenectoplase or Reteplase, was 
administered as soon as the ECG confirmed an STEMI. Paramedics administered 
thrombolysis prior to patient transportation to the nearest accident and emergency 
department or coronary care unit. A blood test to identify elevated Troponin levels 
confirmed the extent of the diagnosis on arrival at hospital.  
The BRI is a tertiary centre providing a twenty-four hour a day PPCI service for the 
wider area of the Southwest region for PPCI and rescue PCI. These areas include Bath, 
Cheltenham, Gloucester, North Bristol, Swindon and North Somerset. The 
introduction of PPCI involved patients going direct to the BRI the moment an STEMI 
was confirmed through ECG recordings, providing the procedure can be carried out 
within two hours from the onset of pain. Thrombolysis is not administered at any 
point.  
Patient admission and treatment data was recorded in the Myocardial Infarction 
National Audit Project (MINAP) by the BRI cardiology department. MINAP data 
provided the initial source of patient selection for this study. MINAP Data shows 863 
patients were treated for STEMI during April 2004 and March 2010. After their initial 
admission, patients were referred back to their own area for cardiology and cardiac 
rehabilitation follow-up. Cardiac rehabilitation is broken down into four phases at the 
BRI: 
 Phase I - Initial event hospital admission. 
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 Phase II - Discharge home. Telephone contact. Pre-assessment clinic. Up to 
four weeks post initial event. 
 Phase III- Comprehensive exercise programme consisting of 1 day per week 
for 8 weeks three weeks post initial event. 
 Phase IV - Discharge to community and PCT. 
For the purpose of this study, selected patients live in the South Bristol area to allow 
for consistency of data throughout their follow-up. Criteria for participants in the 
review also exclude patients with a previous history of MI, depression or known 
mental health issues. The remaining 283 participants were included regardless of their 
age or gender.  
Dr Julian Strange (appendix B) and Dr Tom Johnson appendix C) of the Bristol Heart 
Institute offered support for this study. Alan Davies offered support in accessing data 
(appendix D)  
Formal ethics approval was sought from South West 3 Research Ethics Committee but 
was not required as they considered the study to be a service evaluation. The 
University Of Chester Faculty Of Applied Sciences Research Ethics Committee 
approved this study application with Dr John Buckley acting as supervisor for this 
study (appendix E).  
3.2 Sourcing data 
Patient treatment and demographic information was determined from MINAP data. 
This accounted for the initial selection. After adjustment for exclusion criteria, the 
remaining 282 patients data was matched with Cardiac Rehabilitation PATS data 
(CRPATS). Readmission information was sourced from BRI patient records. Patient 
identification remained anonymous for the purpose of this study.  
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Comparison of MINAP and CRPATS determined referral to cardiac rehabilitation for 
phase I and uptake of the programme. MINAP data provided demographic information 
such as age, gender and current status.  
Repeated measures were obtained for those who completed the cardiac rehabilitation 
pre and post programme questionnaire based on National Audit for Cardiac 
Rehabilitation (NACR) recommended guidelines. CRPATS data incorporates the 
(NACR) dataset along with specific information required for the BRI cardiac 
rehabilitation service. CRPATS provided information on cholesterol, hospital anxiety 
and depression scores (HADS) (appendix F), lifestyle and risk factors for those who 
were referred to the programme (appendix G). The use of HADS is recommended by 
the NACR and is a validated 4-point Likeart scale using 14 items. The 14 items are 
divided into categories: 7 anxiety and 7 depression. A score of > 8 for either indicates 
presence of anxiety or depression respectively with a potential maximum score of 21 
per category.  
3.3 Statistical Analysis  
To determine any significance between patient groups and re-admissions, the data was 
broken down to identify if re-admission was cardiac related or not. Cardiac related 
admissions included chest pain or breathlessness of unknown cause as well as further 
MI or angina related symptoms. Lifestyle, cholesterol and HADS were analysed for 
patients referred to the Cardiac Rehabilitation programme at phase I, attended phase II 
clinic and completed the phase III exercise programme. Risk factors are defined as 
activity, weight, BMI, smoking, alcohol, blood pressure and cholesterol. Risk factors 
were measured at phase 2 of cardiac rehabilitation, when patients attended the cardiac 
pre-assessment clinic, then again at phase three when patients completed the cardiac 
rehabilitation programme. 
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Statistical Package for the Social Sciences (SPSS) was applied for data analysis. 
Independent groups consisted of PPCI and Thrombolysis subjects. Parametric and 
non- Parametric data was determined by type of data, assumptions for normal 
distribution, using Kolmagorov-Smirnov statistic where the sample size is >100, 
Shapiro-Wilks for samples <100 and homogeneity of variance where appropriate. 
Parametric data was analysed using independent t-tests. Paired t-tests were applied to 
repeated measures. Non-parametric data was analysed using Chi Square, Mann 
Whitney U test for independent values, Wilcoxon test for repeated measures and 
Kruskal Wallis for multiple groups. HADS were recorded according to individual 
scores and level of risk i.e. Anxiety score of 1 to 7 = low level risk of anxiety, a score 
of 8 to 21 = moderate to high risk.  Summary statistics of parametric data were 
expressed as means and standard deviations (SD) while those of non-parametric data 
sets are expressed as medians with ranges. Spearman’s correlation was applied to 
investigate links between independent groups that did not assume equal distribution or 
homogeneity of variance or qualify for Pearsons correlation were non-parametric.  
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4:Analysis Results 
MINAP provided initial data. Data included demographic information i.e. age, gender 
and financial year from when PPCI was first properly introduced at the BRI (table 6). 
Table 6: Demographic information 
 Thrombolysis PPCI Total 
Age < 39 1 3 4 
 40 - 49 15 20 35 
 50 -59 21 49 70 
 60 - 69 23 59 82 
 70 - 79 25 37 62 
 > 80 5 24 29 
Total 282 
 
Gender Male 67 139 207 
 Female 22 53 75 
Total 282 
 
Financial 
year 
2004 / 2005 32 11 43 
2005 / 2006 21 8 29 
 2006 / 2007 18 22 40 
 2007 / 2008 4 36 40 
 2008 / 2009 13 55 68 
 2009 / 2010 2 60 62 
Total 282 
 
From this point, patient details were matched with Cardiac Rehabilitation PATS data 
and BRI hospital records. 
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4.1 Re-admission 
General readmissions amounted to 138 (49%) patients, 99 (35%) patients were re-
admitted with cardiac related issues (table 7).   
 
Table 7: Financial year of Primary Event * Re-Admission Crosstabulation 
Financial year of Primary Event Re-Admission 
(%) 
  
 April 2004/05 32 (74) 
April 2005/06 15 (52) 
April 2006/07 22 (55) 
April 2007/08 18 (45) 
April 2008/09 32 (47) 
April 2009/10 19 (31) 
Total 138  
 
A Chi Square test shows significant differences between financial years and 
readmissions (P = .000). The percentage of patients readmitted gets lower for each 
year of initiating event. 
A Chi-square test revealed no significant difference in patient re-admissions between 
Thrombolysis and PPCI.  In terms of time from initial event and re-admission, the data 
did not satisfy assumptions for parametric testing therefore Mann-Whitney U tests 
were applied. Results demonstrate a significant difference between Thrombolysis and 
PPCI patients in terms of length of time before initial cardiac related re-admission 
(Table 8).  
Cardiac related re-admission time:  
P = .049  
Median figures for Thrombolysis = 280 days from initial event to cardiac related re-
admission  
Median figure for PPCI = 182 days from initial event to cardiac related re-admission.  
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Table 8: Readmissions 
Re-Admission 
Data 
Thrombolysis 
n =  90 
(%) 
PPCI 
n=192 
(%) 
Total 
n = 282 
(%) 
P 
Value 
Patients readmitted 53 (58) 85 (44) 139 (49)  
 Chi-Square Sig. P = .092 P = .112   
Days to first 
unplanned re-
admission 
Median 280 182  .034 
 Range 2358 2311   
Patients with Cardiac 
Readmissions 
 
44 (49) 55(29) 99 (35) 1.0 
Days to first 
unplanned Cardiac re-
admission 
Median 289 182  .049 
 Range 2355 1674   
 
A Kruskal-Wallis test showed no significance in financial year and days to unplanned 
cardiac related readmission between each treatment (P = .354). 
Spearman’s correlation analysis was conducted to identify any links with re-
admissions and HAD scores or levels. Data did not achieve assumptions of equal 
distribution, thus, a non-parametric analysis was applied. Results showed a link 
between PPCI total number of cardiac related re-admissions and phase II depression 
scores (P = .024). Correlation co-efficient = .386 (low) = 15% of 28 PPCI patients re-
admitted with cardiac related symptoms.  
Frequency of total general and cardiac related readmissions did not satisfy 
assumptions for parametric tests. Therefore, a Mann Whitney U test was applied.  The 
results show no significant differences between Thrombolysis and PPCI patients (table 
9). 
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Table 9: Mann Whitney U Frequency of admissions 
 Thrombolysis 
n 
PPCI 
n 
P value 
 Min Max Min Max  
Total 
Readmissions 
1 18 1 12 .422 
Total Cardiac 
Related 
Readmissions 
1 16 1 4 .052 
 
4.2 Mortality Rates  
Data was examined to determine the rate of deaths between the two treatment groups. 
The data did not satisfy equal distribution or homogeneity of variance. A Mann 
Whitney U test was conducted using split groups data and comparing groups. No 
significant differences in number of deaths were found amongst each group or 
between grouping variables (table 10).  
Table 10: Mortality 
Treatment                                  Alive or dead at end  
                                                           of study period 
N % P 
value 
Thrombolysis (n=90)                                                
Alive 
Dead 
Total 
79 87 
10 11 1.00 
89 (1 missing)   
PPCI (n=192)                                                            
Alive 
Dead 
Total 
149 78 
22 12 1.00 
171 (21 
missing) 
  
Mann Whitney U grouping variable       
Thrombolysis 
                                                                                   
PPCI 
89 
171 
 .705 
 
A second test determined if there were differences between the time span of initial 
event and death. Again, data did not satisfy equal distribution, therefore, a Mann 
Whitney U test calculated the result (table 11). 
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Table 11: Time from initial event to death 
 Treatment N Median 
(days) 
Range P Value 
Length of time 
until death 
Thrombolysis 10 1329 1663  
PPCI 22 157 179 .001 
Total 32    
 
There is a significant difference between length of time from initial event and death (P 
= .001). PPCI is seen to have a much shorter time span, median 157 days to death 
compared to 1329 days for Thrombolysis patients. A Kruskal Wallis test analysed the 
time span of deaths for each financial year. The result showed a significant difference 
P = .001. Mann Whitney U tests were run to identify the differences (table 12). A 
Bonferroni adjustment for type one error meant results < .008 were significant. 
Table 12: Significant results of time until death 
Financial 
Year 
Median (days) Range (days) P Value 
2004/05 
2008/09 
1639 
136 
1663 
333 
.007 
2005/06 
2008/09 
666 
136 
1241 
333 
.007 
 
4.3 Length of stay 
Length of stay data analysis established significances between Thrombolysis and PPCI 
patients in this study. The data satisfied the assumptions for equal distribution and 
homogeneity of variance. An independent t-test showed a significant difference 
between the two (P = .005) (table 13). PPCI patients had shorter hospital admissions 
following their initial event. 
 
 
Fiona Barnard                    MSc Cardiac Rehabilitation Dissertation.                September 2011 
 
47 
 
Table 13: Comparing length of stay 
 Treatment N  Mean Std. 
Deviatio
n 
P value 
Length of 
Stay 
Thrombolysis 90 8.66 days 8.070 .005 
PPCI 192 5.98 days 7.012 
 
4.4 Cardiac Rehabilitation referrals  
A total of 232 STEMI patients were referred to cardiac rehabilitation, 50 patients were 
not referred. Nominal data was tested using the non-parametric test to determine 
differences in referrals between groups. Mann Whitney U test resulted in no 
significant difference between the two groups (table 14). 
Table 14: Cardiac Rehabilitation Intervention 
CR Phase  Thrombolysis 
Referred 
n = 82(%) 
PPCI 
Referred 
n= 184 (%) 
P 
value 
Phase I:     Seen on ward by CR nurse 41(50) 101(55) 1.0 
Phase II:    Attended pre-assessment 
clinic 
45 (55) 113 (61) 1.0 
Phase III:   Started exercise programme 39 (48) 94 (51) 1.0 
Phase IV:   Completed 8 week exercise 
programme 
21 (26) 54 (29) 1.0 
 
4.5 Anxiety and depression  
4.5.1 STEMI treatment and HADS 
Percentage calculations demonstrate improvements in anxiety and depression levels 
from phase II Cardiac Rehabilitation through to the end of phase III (table 15). 
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Table 15: Comparison of Percentage of HADS levels between STEMI patients 
HADS level Thrombolysis  % 
n = 37 (53 missing) 
PPCI  % 
n = 84 (108 missing) 
Total 
= n  
 Phase II n= 37 (53 
missing) 
Phase II n= 84 (108 
missing) 
 
Phase II anxiety <8 51% 68% 76 
Phase II anxiety >8 49% 32% 45 
Phase II depression <8 81% 79% 96 
Phase II depression > 8 23% 21% 25 
 Phase III n= 21 (69 
missing) 
Phase III n= 54 (138 
missing) 
 
Phase III anxiety <8 57% 81% 56 
Phase III anxiety >8 43% 19% 19 
Phase III depression <8 95% 85% 66 
Phase III depression > 8 5% 15% 9 
 
Comparison of STEMI patient numbers demonstrates the transition of HADS levels 
over the course of the Cardiac Rehabilitation programme (figure 1). The general trend 
is of a reduction in all HAD scores and levels. 
 
Figure 1: Comparison of STEMI patient numbers and HADS levels 
HAD scores and levels were tested to identify differences between the groups at each 
stage of cardiac rehabilitation HAD Scores were tested for equal distribution and 
homogeneity of variance. Anxiety scores at phase II satisfied assumptions of 
0 
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Thromb PPCI 
Chart Title 
Phase II anxiety < 8 
Phase II anxiety > 8 
Phase III anxiety < 8 
Phase III anxiety > 8 
Phase II depression < 8 
Phase II depression >8 
Phase III depression < 8 
Phase III depression >8 
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distribution and variance. A t-test showed no significant difference between 
Thrombolysis and PPCI anxiety scores at phase II (P = .272) (table 16). 
Table 16: HADS scores and levels independent variables  
HADS Phase II P value Phase III P 
value 
Thrombolysis PPCI  Thrombolysis PPCI  
Anxiety 
Score 
Mean = 6.38 
 
Mean = 
5.35 
 
.272 Median = 4 Median = 5 .781 
Depression 
Score 
Median = 4 Median = 2 .613 Median = 2 Median = 
1.5 
.472 
Anxiety 
level 
Median = 1 Median = 1 .085 Median = 1 
Range = 1 
Median = 1 
Range = 1 
.031 
Depression 
level 
Median = 1 Median = 1 .754 Median = 1 Median = 1 .232 
 
The remaining HAD scores did not meet the assumptions of distribution or variance.  
HADS levels are deemed non-parametric as they were classed low or high. HAD 
Scores and levels were tested as independent groups using Mann Whitney U test.  
Results showed significance for phase III anxiety levels (P = .031) (table 16). Median 
and ranges all equal one. To clarify this result percentages between the two groups 
demonstrate the different outcomes at phase III (table 15): 
Thrombolysis anxiety levels at phase III < 8 = 57%, > 8 = 43% 
PPCI anxiety levels at phase III <8 = 81%, > 8 = 19% 
Repeated HADS measures were analysed using the Wilcoxon analysis, as data is non-
parametric (table 17). Thrombolysis repeated depression levels and scores resulted in a 
value of P = .037 demonstrating a significant reduction in scores and levels between 
phases.  
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Table 17: Wilcoxon test of repeated HAD scores and levels 
Treatment Anxiety 
Score at 
Phase 3 - 
Anxiety 
Score at 
Phase 2 
Post 
Anxiety 
level - 
Pre 
Anxiety 
level 
Depression 
Score at 
Phase 3 - 
Depression 
Score at 
Phase 2 
Post 
Depression 
level - Pre 
Depression 
level 
Thrombolysis Asymp. Sig.  
(2-tailed) 
.294 .564 .037 .046 
Median 
(range) 
   II = 4 (10) 
III = 2 (8) 
II = 1 (1) 
III = 1 (1) 
 
PPCI Asymp. Sig.  
(2-tailed) 
.260 .480 .223 1.000 
 
4.5.2 Gender and HADS 
A Mann-Whitney U analysis determined if gender differences existed between the two 
MI groups HADS scores. In terms of gender and HADS at phase II, no significant 
differences were identified (table 18).  
Table 18: Mann Whitney U test phase II HADS with Gender grouping variable 
Treatment Anxiety 
at Phase 
II 
Anxiety 
at Phase 
III 
Depression 
at Phase II 
Depression 
at Phase III 
Thrombolysis 
n = males 17 
      females 3 
P value .261 .136 .249 .327 
PPCI 
n = males 40 
     females14 
P value .257 .019 .648 .496 
 
However, phase III testing demonstrates a significant result between Anxiety scores 
and gender for PPCI the descriptive data shows: 
Males    = median 4   range 13 
Females = median 7 range 12 
The results signify higher levels of anxiety among PPCI females at phase III of cardiac 
rehabilitation.  
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4.5.3 Age and HADS 
Age was divided into 6 groups. Each group represents ages at ten-year intervals i.e.  
1 = <39  
2 = 40 - 49 
3 = 50 - 59 
4 = 60 - 69 
5 = 70 - 79 
6 = >80 
Age and HADS scores were compared for differences between PPCI and 
Thrombolysis. Phase II and III HAD scores and ages did not meet assumptions of 
equal distribution. A Kruskal-Wallis analysis was applied for the multiple groups 
(table 19). No significance was found between the groups. 
Table 19: Kruskal-Wallis test of age and HAD scores for STEMI patients  
Treatment Anxiety 
at Phase 
II 
Depression 
at Phase II 
Anxiety 
at Phase 
III 
Depression 
at Phase III 
Thrombolysis P 
value 
.221 .810 .208 .503 
PPCI P 
value 
.240 .462 .847 .471 
 
4.5.4 Length of Stay and HADS 
Spearman’s correlation analysed relationships between length of stay and HADS 
(table 20). Results revealed Thrombolysis anxiety scores and levels at correlate at 
phase III: P = .031 and P = .009 respectively. Depression levels correlate with length 
of stay for phase II thrombolysis patients P = .041.  
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Table 20: Comparing PPCI and Thrombolysis correlation of length of stay (LOS) and HADS  
HADS LOS  
Thrombolysis      P value 
LOS  
PPCI                    P value 
 Phase II Phase III Phase II Phase III 
Anxiety score .411 .031 
Correlation co-
efficient -.470 
(modest) 
 
.108 .418  
Anxiety level .461 .009  
Correlation co-
efficient -.552 
(modest) 
 
.262 .136 
Depression 
Score 
.671 .790 .873 .082 
Depression 
level 
.041 
Correlation co-
efficient -.338 
(low) 
.255 .754 .845 
 
Correlation co-efficient relates to the strength of the relationship (Cohen & Holliday, 
1996). The strength of correlation is moderate for both anxiety measures. Depression 
level correlation is low.  
Thrombolysis anxiety score at Phase III indicates a 22% co-efficient of determination 
with length of stay. 
Thrombolysis anxiety level at phase III indicates a 30% co-efficient of determination 
with length of stay. 
Thrombolysis depression level at phase II indicates an 11% co-efficient of 
determination.  
In all three results, the correlation is negative indicating an increase in the significant 
HADS results to a decrease in length of stay.  
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4.6 Risk Factors 
 
4.6.1 Risk factors between STEMI treatments 
 
Paired testing was applied to investigate differences between Thrombolysis and PPCI 
repeated measures of risk factors for heart disease between phases II and III Cardiac 
Rehabilitation (table 21). None of the paired data satisfied equal distribution and 
homogeneity of variance therefore the non-parametric Wilcoxon test was applied.  
Cholesterol and Smoking show improvements between phase II and III in both 
treatments. Activity has decreased in both treatments between phases. However, in all 
significant cases PPCI has shown better results in risk management. Furthermore, 
weight management and BMI only showed significant improvements in the PPCI 
group. 
Table 21: Compared repeated tests for risk factors between treatments 
Risk factor(n) Thrombolysis PPCI 
 Sample 
Size  
(n = 90) 
P 
value 
Phase 
II 
Median 
(range) 
Phase 
III 
Median 
(range) 
Sample 
Size 
(n = 
192) 
P 
value 
Phase II 
Median 
(range) 
Phase 
III 
Median 
(range) 
Cholesterol 
(mmol/l) 
19 .001 5.9 
(3.4) 
3.8 (4) 50 .000 5.3 (7.8) 4.3 (8) 
Systolic BP 
(mm/Hg) 
25 .054 125 
(82) 
116 
(64) 
69 .644 120 (86) 120 (75) 
Diastolic BP 
(mm/Hg) 
24 .875 75 (47) 78 (37) 66 .886 72 (52) 70 (50) 
Smoking 
 
23 .046 5 
smoke 
1 
smoke 
67 .008 14 
smoke 
7 smoke 
Weight (Kg) 
 
19 .266 76 (47) 75 (46) 50 .002 80 (77) 78 (86) 
BMI 
 
17 .109 25 (13) 25 (11) 48 .001 26 (18) 26 (20) 
Alcohol 
(units /week) 
17 .310 2 (35) 4 (30) 52 1.0 3 (30) 4 (30) 
Activity 
(hours /week) 
17 .006 2 (2) 1 (2) 59 .000 3 (2) 2 (2) 
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4.6.2 Risk Factors and Length of Stay: 
A correlation test evaluated links between length of stay and risk factor management. 
The data did not satisfy equal distribution. A Spearman correlation test was applied 
(table 22).  
Table 22: Correlation of risk factors and length of stay 
 
Length of stay 
Risk Factor phase II P value Phase III P value 
cholesterol 
(mmol/l)  
.870 .418 
Systolic 
(mmol/Hg) 
1.0 .734 
Diastolic 
(mmol/Hg) 
.012 
Correlation Coefficient = -.187 
Very low (3%) 
.646 
Smoking .506 .521 
Weight (Kg) .010 
Correlation coefficient = -.168 
Very low (2.8%) 
.421 
Alcohol  
(units / week) 
.033 
Correlation coefficient = -.171 
Very low (2.9%) 
.834 
Activity  
(hours / week) 
.301 .983 
 
Phase II correlations show a negative correlation in diastolic blood pressure, weight 
and alcohol. Indicating a decrease in the risk factors compared to an increase in length 
of stay at phase II. The correlations were low so not of great significance. 
4.6.3 Age, Gender and risk factors 
Investigation of age and gender determined if differences occurred in relation to risk 
factor management for BRI patients. The study consists of 206 men and 75 females 
(table 23). 
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Table 23: Age at time of initial event * Gender Cross tabulation 
 Gender Total 
Male Female 
Age at time of 
initial event 
< 39 3 1 4 
40 - 49 31 4 35 
50 - 59 58 12 70 
60 - 69 63 19 82 
70 - 79 42 19 61 
>80 9 20 29 
Total 206 75 281 
 
Neither gender nor age meet the assumptions for equal distribution and are therefore 
measured using non-parametric tests. The age group consists of 6 groups. A Kruskal- 
Wallis test identified if there were significant differences between age and risk factors 
(table 24).  
 
Table 24: Age related repeated risk factor measures  
Risk factor for age Phase II  
p value 
Phase III 
p value  
Systolic Blood Pressure (mmHg)  .889 .662 
Diastolic Blood Pressure (mmHg) .750 .506 
Cholesterol (mmol / l) .735 .521 
Smoking .003 .680 
Weight (Kg) .000 .004 
Alcohol (units / week) .001 .229 
Activity (hours / week) .043 .580 
 
Significant results included smoking, weight, alcohol and activity, were tested using 
Mann Whitney U tests. A Bonferroni adjustment prevents a type one error, due to 
multiple testing of each sample group:  P = .05 / 6 = < .008 (table 25). 
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Table 25: Mann Whitney U significant results of age and risk factors with Bonferroni adjustment 
Risk 
Factor 
Significant age 
groups 1 (n) 
 
median 
(range) 
Median Significant 
age group 2 (n) 
Median 
(range) 
P 
value 
Smoking 
phase II 
40 - 49 (35) 
(23 still smoked) 
1 (1) 
 
70 - 79 (59) 
( 18 still smoked) 
2 (1) .001 
> 80 (28) 
(5 still smoked) 
2 (1)  .000 
Weight 
Kg 
phase II 
40 - 49 (29) 85 (78) > 80 (22) 64 (30) .000 
50 - 59 (58) 
 
86 (75) 
 
60 - 69 (30) 72 (64) .000 
70 - 79 (52) 76 (71) .000 
> 80 (22) 70 (60) .000 
Weight 
phase 
III 
50 - 59 (13)  85 (55) 70 - 79 (18) 70 (41) .001 
Alcohol 
phase II 
50 - 59 (37) 
 
10 (42) 
 
60 - 69 (53) 1 (40) .000 
70 - 79 (38) 1 (28) .001 
Activity 
phase II 
50 - 59 (37) 2 (2) 60 - 69 (53) 2 (2) .000 
70 - 79 (38) 3 (2) .001 
 
Results show fewer people smoked in the older age groups at point of their initiating 
event. Weight was lower in 60 to > 80 age group for both phases. Alcohol 
consumption was higher in the mid rang group of 50 - 59 and activity slightly lower. 
A Wilcoxon test was applied to identify significant differences in gender and risk factors 
at each phase of Cardiac Rehabilitation. There are significant differences in all risk factors 
between gender and repeated tests (table 26). In phase III: 
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Table 26: Wilcoxon test results for Gender and Risk factors  
Risk factor 
(Gender) 
Phase II  Phase III 
 p 
value 
Male 
median 
(range) 
(n) 
Female 
median 
(range) 
(n) 
p 
value 
Male 
median 
(range)  
Female 
median 
(range) 
Systolic Blood 
Pressure 
(mmHg)  
.000 120 (74) 
(70)  
123 (86) 
(23) 
.000 120 
(75) 
118 
(74) 
Diastolic Blood 
Pressure 
(mmHg) 
.000 72 (54)  
(69) 
72 (45) 
(20) 
.000 70 (45) 76 (45) 
Cholesterol  
(mmol / l) 
.000 5.4 (5.4) 
(52) 
6 (6)  
(16) 
.000 4 (5) 4.7 (7) 
Smoking .000 2 (1)  
(67) 
2 (1)  
(22) 
.000 2 (1) 
4 
smoke 
2 (1) 
4 
smoke 
Weight (Kg) .000 81 (77) 
(54) 
66 (43) 
(14) 
.000 79 (86) 67 (36) 
Alcohol (units / 
week) 
.000 3 (35) 
(54) 
2 (30) 
(14) 
.000 4 (30) 3 (14) 
Activity (hours 
/ week) 
.000 3 (2)  
(57) 
3 (2)  
(19) 
.000 1 (2)  2 (2) 
 
Systolic blood pressure is unchanged in males and reduced in females. Diastolic blood 
pressure reduced for males, increased for females. Cholesterol has reduced for both at 
an almost equal rate. Ratio of smokers is less for males. Weight reduced for males and 
increased for females. Female weight is generally lower. Alcohol increased by 1 unit 
for both genders. Activity reduced for both but a greater decrease for males. 
 
 
 
 
 
Fiona Barnard                    MSc Cardiac Rehabilitation Dissertation.                September 2011 
 
58 
 
5: Discussion:  
5.1 Unplanned readmissions  
The percentage of patient unplanned readmissions was lower for PPCI over the course 
of the study. However, when running statistical tests the difference was insignificant in 
comparison to Thrombolysis patients. The lower percentage of PPCI patients could be 
interpreted as a promising trend towards fewer readmissions in the newer, more 
favoured PPCI treatment.  In contrast, differences in percentage maybe explained by 
the point in time each patient entered the study. Thrombolysis was a commonplace 
treatment during the early years of the study, but became fewer as PPCI took over. In 
some cases, first readmission was up to six years after the initial event. Overall, 
figures show readmitted patients are fewer for those whose initiating event is most 
recent.  
5.2 Frequency of  unplanned readmissions  
The significant differences in time before unplanned readmission support the 
aforementioned theory as both general and cardiac readmissions were over a shorter 
period for PPCI patients, P = .034 and P = .049 respectively. However, the number of 
readmissions remains insignificant per financial year. Furthermore, there was no 
significant difference found between financial years of initial events and the time 
before re-admission. Prospective study of PPCI patient outcomes may see the 
correlated difference even up over time. 
Links between anxiety and depression in terms of readmissions revealed a correlation 
of P = .024 between PPCI total number of cardiac related re-admissions and phase II 
depression scores. The correlation co-efficient P = .386 is classed as low. The positive 
correlation implies higher PPCI patient depression score at phase II equates to more 
likely they will have multiple cardiac related unplanned readmissions. The relevant 
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correlation relates to 15% of 28 PPCI patients or 1 in 7 of cardiac related 
readmissions. Although the relationship may appear small, evidence has suggested 
even small increases in depression or anxiety can influence patient outcomes (Bush, et 
al 2001). Implications are for health professionals to be vigilant in assessing patients in 
the earlier stages following their event. Cardiac rehabilitation phase II HADS 
assessments at the BRI are often recorded as a baseline and reassessed at phase three, 
if the patients complete the programme. The authors experience has shown patients to 
be reluctant to act upon issues of anxiety and depression in the early weeks of 
recovery, but may seek GP advice if problems persist at phase III.  More emphasis on 
educating patients and health professionals of the associated issues with CHD and 
depression could assist toward improving patient outcomes. Furthermore, better 
liaison between Cardiac Rehabilitation nurses and GPs, at all phases of the patient 
journey, may help to improve monitoring and early treatment of patients’ emotional 
issues thus reducing readmissions and proving cost effective in the long term. 
5.3 Mortality rates  
Analysis of overall mortality rates concluded no significant difference between 
Thrombolysis and PPCI patients with a percentage of 11% and 12 %, respectively. 
However, time from initial event to death had a significant value of P = .001indicating 
significant differences. The PPCI group was found to have a shorter time span 
between initial event and death with a median of 157 days compared to 1329 for the 
Thrombolysis group. To clarify if the significance related to time of initiating event, 
analysis of financial years of initiating event and time until death was carried out and 
also revealed significant differences. However, following adjustments for multiple 
tests there was no significant differences between PPCI and Thrombolysis groups for 
each financial year. There were, however, significant differences between years for all 
STEMI patients. The year 2004/05 has a median of 1639 days before death, whereas 
Fiona Barnard                    MSc Cardiac Rehabilitation Dissertation.                September 2011 
 
60 
 
2008/09 is 136 days. PPCI patients were predominantly treated during the latter years 
of the review, therefore, as with results for unplanned readmissions, the time from 
initiating event and death is likely to alter prospectively. Even so, the statistic should 
not be ignored but be highlighted to ensure close monitoring of patient deaths 
continues with a view to examine and improve patient risks. 
5.4 Length of hospital stay  
A previous study identified PPCI patients to have a shorter length of hospital stay at 
the BRI (Oriolo & Tagney, 2011). The resulting evidence from this review confirms 
PPCI patients had shorter hospital admissions following their initial event (P = .005). 
Over the study period, PPCI patients stayed for an average of 6 days whereas 
Thrombolysis patients averaged 9 days. Oriolo and Tagney (2011) have reduced PPCI 
admission time in the last three years to average 2.7 days. 
The correlation between length of stay and cardiac rehabilitation phase III anxiety 
scores (P = .031) and levels (P = .009) in thrombolysis patients showed a modest 
negative correlation co-efficient rating of  P = -.470 and P = -.552 respectively. 
Results indicate an increase in anxiety at phase III in relation to a shorter length of stay 
in hospital. A low negative correlation for thrombolysis and depression at phase II 
(0.041) indicates increased levels of depression in the early weeks of recovery for 
patients with shorter hospital admissions. However, depression levels improved for 
patients completing cardiac rehabilitation phase III. The results imply patient anxiety 
and depression levels have improved with the introduction of PPCI despite shorter 
hospital admissions. One explanation for improvement is through developments within 
the cardiac rehabilitation service. Cardiac rehabilitation specialist nurses aim to visit 
all MI patients and advise them on disease and risk factor management prior to 
discharge. Information and literature is constantly being updated to ensure patients are 
clear about current issues related to their CHD diagnosis, treatments and recovery.   
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5.5 Uptake of cardiac rehabilitation  
No significant differences for referrals to Cardiac Rehabilitation were found between 
the two groups. In fact, referrals and uptake of phase II and III remain consistent for 
both thrombolysis and PPCI patients. The results iimply no difference in complacency 
among PPCI patients compared Thrombolysis patients. The benefits of Cardiac 
Rehabilitation are undeniable in terms of all cause mortality (Jolliffe et al 2001) and 
readmission (Heran et al 2011). The NSF (2000) aim for 85% of all eligible patients 
being offered Cardiac Rehabilitation is met by the BRI team through ward contact and 
invite letters sent to patients on discharge. However, only 55 to 61% of the STEMI 
groups are responding to the invite and a maximum of 29 % are completing phase III. 
In terms of uptake and completion of the cardiac rehabilitation course at the BRI, vast 
improvements are necessary to increase patient interest.  
5.6  Anxiety and depression levels between phases  
Analysis demonstrates differences in anxiety levels between the STEMI groups. 
Significantly lower levels of anxiety are apparent in PPCI patients at phase III 
compared with Thrombolysis (P = .031).  
Thrombolysis anxiety levels at phase III  < 8 = 57%   > 8 = 43% 
PPCI anxiety levels at phase III   <8 = 81%,  > 8 = 19% 
Thrombolysis repeated depression levels and scores resulted in a value of P = .037 
demonstrating a significant reduction in scores and levels between phases. These 
results are in agreement with length of hospital stay results. 
The general trend for both groups is a reduction in anxiety and depression across both 
phases. However, PPCI patient depression levels do not reduce to the same extent as 
Thrombolysis patients at phase III: 
PPCI depression score > 8 = 21% at phase II and 15% at phase III 
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Thrombolysis depression score > 8 = 23% at phase II and 5% at phase III 
Evidence has demonstrated strong links with depression and mortality following an 
MI. The results, although not entirely significant in terms of analysis tests, may have 
some bearing on the significant results regarding PPCI length of time until death. 
However, the data in this study is limited and does not allow for analysis of phase III 
HADS scores and death rates due to most subjects completing phase III are recorded 
as still alive. Further investigation, through prospective study, is necessary to identify 
if there is a link.  
Age had no bearing on HADS results but gender related analysis revealed female 
anxiety scores were higher than males at phase III (P = 0.019). A median of seven 
indicates scores to be bordering just below the level of concern but imply levels to be 
generally higher in females in accordance with Naqvi et al (2005) who noted 
depression levels are higher in women post MI. A low number of Thrombolysis 
female patient data made it difficult to assess phase III anxiety levels although the 
median = 9 for three females compared to median = 4 for 17 males. 
5.7  Risk factors  
5.7.1 Risk factors and length of hospital stay 
When analysing the effect of length of hospital stay on risk factor management, results 
concluded a negative correlation in diastolic blood pressure, weight and alcohol at 
phase II. Indicating a decrease in the risk factor measurement compared to an increase 
in length of hospital stay and vice versa. Although the correlations were low and not 
considered of great significance, any threat to mortality or secondary event post MI 
should be seen as important and in need of further preventative intervention. Phase II 
assessment at the BRI occurs at approximately 2 to 4 weeks post initial event. One 
explanation for the negative correlation may relate to initial reaction to medication, 
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treatment, loss of appetite and desire for alcohol. Phase III sees no correlation, 
possibly because patients are more comfortable with their diagnosis and medications 
have been titrated to suit their blood pressure. A number of patients had stopped 
smoking thus possibly experiencing weight gain as a result. However, PPCI hospital 
admissions are much shorter, therefore, more emphasis is necessary on management of 
weight, alcohol intake and screening for blood pressure when educating patients at 
discharge and throughout their follow-up. This information should not be delivered by 
Cardiac Rehabilitation nurses alone, but involvement of GP’s, cardiologists and other 
allied healthcare professionals would ensure consistent reinforcement of risk factor 
advice in post MI patient care.  
5.7.2 Risk factors between phases 
Cholesterol and Smoking have improved between phase II and III in both treatments 
indicating consistent compliance to medication, dietary and smoking advice. However, 
smoking remains a difficult issue. The smoking cessation service in Bristol is currently 
offering incentives to Health Authorities in order to increase referrals for patients who 
express a desire to stop smoking.  
An area of concern is the decrease in activity for both treatments between phases. One 
explanation for this is patients interpretation of the activity questionnaire. Anecdotal 
reports, experienced by the author, indicate patients misinterpreting the questionnaire 
when completing it for phase II. Many patients report shopping, housework and going 
upstairs as exercise. On completing phase III cardiac rehabilitation exercise 
programme, it is possible patients have a better understanding of activities and 
exercise, thus report their activities more accurately.  Another explanation relates to a 
number of patients who feel they have achieved their desired level of exercise and fail 
to complete the programme thus not submitting the ‘post assessment’ questionnaire.  
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Despite the issues mentioned, the significant risk factors results are more favourable in 
the PPCI patient group. Furthermore, weight management and BMI showed significant 
improvements in the PPCI group but not for Thrombolysis patients. 
One can assume from these results that PPCI patients are not complacent about 
managing risk factors compared to Thrombolysis patients. 
 5.7.3 Risk factors and age 
Results for risk factor and age analysis identified fewer people smoked in the older age 
groups (>70 years) at point of their initiating event. The 40 - 49 years group had a 
higher number of smokers at their initial event. Weight was significantly lower in 60 
to > 80 age group for both phases. Alcohol consumption was higher in the mid rang 
group of 50 - 59 and activity slightly lower. All the significant results relate to co-
morbid risk factors that are less prevalent issues in the older generations. This may be 
due to survival aspects of persistently poor management of risk factors meaning 
people die younger when they drink, smoke, are overweight or not very active. Results 
may also indicate a tendency for people to review their lifestyle as they get older in 
order to maintain a better quality of life. 
5.7.4 Risk factors and gender 
Significant differences resulted in all risk factors between gender and both phases of 
cardiac rehabilitation. 
• Systolic blood pressure is unchanged in males with a significant drop in blood 
 pressure range in females.  
• Diastolic blood pressure range reduced for males, median figure increased for 
 females. 
• Cholesterol has reduced for both at an almost equal rate however, the females 
 cholesterol range has increased. 
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• Ratio of smokers is less for males, only 4 smoked within both genders at phase 
 III, however only 22 female data was recorded compared to 67 males. 
• Weight reduced for males and increased for females. Female weight is 
 generally lower. 
• Alcohol increased by 1 unit for both genders. 
• Activity reduced for both but a greater decrease for males. 
The data demonstrates poorer outcomes in terms of risk factor management for 
women. Completion of the cardiac rehabilitation programme was generally lower for 
females included in the review: 29% males completed compared to 20% females. 
Implications of the results between gender indicate motivating females to attend the 
cardiac rehabilitation programme and develop better methods to encourage improving   
and maintaining risk factors and lifestyle management in the long term.  
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6. Conclusion 
The question raised at the beginning of this study involved identifying differences 
between Thrombolysis and PPCI patients short-term recovery from an STEMI in the 
South Bristol area. Reviewing patients progress through cardiac rehabilitation has 
answered many aspects of the initial question but also raised many more. One can 
assume from results, PPCI patients are not complacent about managing risk factors 
compared to Thrombolysis patients despite their HADS scores. However, length of 
stay does have a bearing on anxiety and depression as well as certain risk factors. 
Further investigation is necessary to establish if early depression levels link to early 
readmissions and premature deaths for PPCI patients.  
Assessment of patients in the early days following their STEMI should account for 
length of stay and include greater emphasis on management of lifestyle, ensuring 
regular monitoring of CHD related risk factors continues after discharge. Allied health 
professionals may benefit from a greater understanding of the effects of anxiety and 
depression in the early weeks and long term following an MI and be encouraged to act 
upon elevated HADS at the earliest opportunity rather than monitor for signs of 
improvement. In turn, patient outcomes could benefit if encouraged to seek advice 
where anxiety or depression scores are elevated at any point during their recovery.  
It is concerning that activity levels appear to decrease by the end of phase III Cardiac 
Rehabilitation. Further investigation would help to identify if the decrease is due to 
misinterpretation of the questionnaire or lack of motivation. An additional concern 
involves outcomes for female patients seeming to be poorer compared to males. More 
data is needed to identify if this a consistent problem. Many previous studies into 
CHD have expressed the lack of data related to females and their outcomes. 
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Improving communication between secondary and primary care at all phases of 
patients recovery, would ensure monitoring of patients remains regular and consistent 
as well as allowing opportunities for patients and health allied healthcare workers to 
express concerns about individual and general management of CHD patients. 
Certain constraints resulted in limited data for analysis throughout this review. 
Constraints were mainly due to patients not referred to the Cardiac Rehabilitation 
Service, not accepting the invitation to phase II cardiac rehabilitation, not attending the 
exercise programme or not completing the exercise programme. The South Bristol 
Cardiac Rehabilitation team continue to strive toward increased uptake of the Cardiac 
Rehabilitation programme. Improved liaison with Cardiologists, GP’s and CHD 
practice nurses may assist in influencing patients to attend and complete the Cardiac 
Rehabilitation programme, thus contributing to reducing all cause mortality and 
readmissions therefore proving cost effective to the health service. 
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8. Appendix A: BRI Nurse Led Discharge Protocol for PPCI patients 
 
PPCI -REPERFUSION TIME 0 
CCU 
12HRS PATIENT STABLE* 
 (SYSTOLIC BP> 100 mmHg - NO NEW ECG CHANGES - PAIN FREE - SaO2>93%) 
SPR/CCU TO BOOK ECHO 
TRANSFER 
TO WARD 51/53 
24 HRS  
PATIENT STABLE * (AS ABOVE) 
DEMONITOR + 
ECHOCARDIOGRAM+ 
REHAB REFERRAL 
TTA’S, D/C LETTER, MINAP, 
REHAB TO SEE 
36 HRS  
PATIENT STABLE* (AS ABOVE) 
EF≥ 40% & KILLIP I 
48 HRS 
PATIENT STABLE* (AS ABOVE)  
BLOODS, ECG, COPY OF 
PROCEDURE,  
VENFLON OUT, MINAP 
HOME 
TO BE SEEN BY 
ACS NURSE/DR 
ECHO PERFORMED? 
Y N 
ARRANGE  
ASAP 
EF≤ 39%  
DR R/V 
SCREEN FOR ICD 
 * IF PATIENT UNSTABLE AT ANY STAGE PLEASE D/W DR/ACS NURSE 
PPCI NURSE LED DISCHARGE PROTOCOL 
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Appendix B: Letter from Dr Julian Strange 
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Appendix C: Letter from Dr Tom Johnson 
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Appendix D: Letter from Alan Davies 
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Doctors are aware that emotions play an important part in most illnesses.  If your doctor knows about 
these feelings he will be able to help you more. 
This questionnaire is designed to help your doctor to know how you feel.  Read each item and place a 
firm tick in the box opposite the reply, which comes closest to how you have been feeling in the past 
week. 
Don’t take too long over your replies: your immediate reaction to each item will probably be more 
accurate than a long thought-out response. 
Tick only one box in each section 
I feel tense or ‘wound up’:     I feel as if I am slowed down:    
Most of the time ..................................      Nearly all the time ...............................     
A lot of the time ..................................      Very often ............................................     
Time to time, Occasionally .................      Sometimes ...........................................     
Not at all ..............................................      Not at all ..............................................     
I still enjoy the things I used to enjoy: 
    
I get a sort of frightened feeling like 
‘butterflies’ in the stomach: 
   
Definitely as much ..............................      Not at all ..............................................     
Not quite so much ...............................      Occasionally ........................................     
Only a little ..........................................      Quite often ...........................................     
Hardly at all .........................................      Very often ............................................     
I get a sort of frightened feeling as if 
something awful is about to happen: 
    
I have lost interest in my appearance: 
   
Very definitely and quite badly ...........      Definitely .............................................     
Yes, but not too badly .........................      I don’t take so much care as I should ..     
A little, but it doesn’t worry me ..........      I may not take quite as much care .......     
Not at all ..............................................      I take just as much care as ever ...........     
I can laugh and see the funny side of 
things: 
    I feel restless as if I have to be on the 
move: 
   
As much as I always could ..................      Very much indeed................................     
Not quite so much now .......................      Quite a lot ............................................     
Definitely not so much now ................      Not very much .....................................     
Not at all ..............................................      Not at all ..............................................     
Worrying thoughts go through my mind:    I look forward with enjoyment to things: 
  
A great deal of the time .......................      As much as I ever did ..........................     
A lot of the time ..................................      Rather less than I used to .....................     
From time to time but not too often ....      Definitely less than I used to ...............      
Only occasionally ................................      Hardly at all .........................................     
I feel cheerful:     I get sudden feelings of panic: 
   
Not at all ..............................................      Very often indeed ................................     
Not often .............................................      Quite often ...........................................     
Sometimes ...........................................      Not very often ......................................     
Most of the time ..................................      Not at all ..............................................     
I can sit at ease and feel relaxed: 
    
I can enjoy a good book or radio or 
TV programme: 
   
Definitely ............................................      Often ....................................................     
Usually ................................................      Sometimes ...........................................     
Not often .............................................      Not often ..............................................     
Not at all ..............................................      Very seldom ........................................     
 
Hospital Anxiety Depression – Scale Results Sheet 
 
  A D    A D 
  3      3 
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  2      2 
  1      1 
  0      0 
 
 
  
A 
 
D 
    
A 
 
D 
   0    0  
   1    1  
   2    2  
   3    3  
 
 
  
A 
 
D 
    
A 
 
D 
  3      3 
  2      2 
  1      1 
  0      0 
 
 
  
A 
 
D 
    
A 
 
D 
   0    3  
   1    2  
   2    1  
   3    0  
 A D   
 
A 
 
D 
  3      0 
  2      1 
  1      2 
  0      3 
 
 
  
A 
 
D 
    
A 
 
D 
   3    3  
   2    2  
   1    1  
   0    0  
 
 
  
A 
 
D 
    
A 
 
D 
  0      0 
  1      1 
  2      2 
  3      3 
  
FOR HOSPITAL USE ONLY 
 
SCORE A = ……….  
 D = ………. 
 
 
 
 
 
Appendix G: Risk Factor Questionnaire 
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Smoking 
• How would you describe your smoking habit? 
 
 
Not smoked for over one month........................  
 
 
 
• Would you like more  
Diet 
 
 
• How much alcohol do you drink per week?........................ 
Physical Activity 
1. Considering a 7-day period (a week), how many times 
on average do you do the following kinds of exercise for 
more than 15 minutes? 
a. Strenuous Activity (heart beats rapidly/tiring)?  
 (e.g. running, jogging, vigorous long distance 
 cycling, circuit training, aerobic dance, skipping, 
 football, squash, basketball, roller skating, 
 vigorous swimming) 
b. Moderate Activity (not exhausting)?  
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 (e.g. fast walking, mowing the lawn, tennis, easy 
 cycling, badminton, easy swimming, ballroom 
 dancing, fast or high step ups) 
 
 (e.g. easy walking, slow dancing, standing active 
 fishing, bowling, golf, low step-ups) 
2. Considering a 7-day period (a week), how often do you 
engage in any regular activity long enough to work up a 
sweat (heart beats rapidly)? 
 A Often 
 B Sometimes 
 C Never/Rarely 
3. Do you take regular physical activity of at least 
30 minutes duration on average 5 times a week? 
 A Yes 
 B No 
4. What type of activity do you enjoy? 
5. What are your goals? 
